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ABSTRACT 
Microfibers are becoming increasingly important for biomedical applications such as 
tissue engineering, drug delivery, and cell encapsulation. In this study, a microfluidic approach 
was used to fabricate biocompatible and biodegradable polymeric fibers. Chapter one gives an 
overview of the common microfiber fabrication methods followed by their advantages and 
disadvantages. Then, it focuses on the microfluidic platform and provides more information about 
different solidification strategies applied to fabricate fibers in this method. This chapter reviews 
some studies, which were recently published in this area as well.  
Chapter two discusses using the microfluidic approach to fabricate continuous Polyvinyl 
alcohol (PVA) microfibers. It was shown that the size and cross-section of the PVA fibers can be 
controlled by changing the PVA concentration and flow rate ratio between the core and sheath 
fluids. The PVA concentration was varied from 6% to 12%, and the sheath-to-core flow rate ratio 
used for this study was in the range of 500:5 µL/min to 500:20 µL/min, respectively. The ribbon- 
shaped PVA fibers were fabricated using our microfluidic approach. Additionally, we simulated 
the microfluidic fiber fabrication process and the results consisted well with the experimental 
results. The dissolution and mechanical properties of the PVA fibers fabricated with different 
characteristics were also studied.  
Chapter three focuses on fabricating polycaprolactone (PCL) microfibers using the 
microfluidic approach. It was shown that through variations of the sheath fluid flow rate and PCL 
concentration in the core solution, the morphology of the fibers and their cross sections can be 
tuned. The fibers were made using PCL concentrations of 2%, 5%, and 8% in the core fluid with 
a wide range of sheath-to-core flow rate ratios from 120:5 µL/min to 10:5 µL/min, respectively. 
The results revealed that the mechanical properties of the PCL fibers made using microfluidic 
approach were significantly improved compared to the PCL fibers made by other fiber fabrication 
xv 
 
 
methods. Additionally, the effects of flow rate ratio and PCL concentration on the mechanical 
properties of the PCL fibers were studied.  
In chapter four, the PCL microfibers with different characteristics were used as fibrous 
scaffolds to get one step closer to the application of the polymeric fibers in tissue engineering. 
Adult Hippocampal Stem/Progenitor Cells (AHPCs) in vitro were chosen for this study. It was 
shown that the three-dimensional topography of the PCL substrates, along with chemical 
(extracellular matrix) guidance cues, supports the adhesion, survival, and differentiation of the 
AHPCs. Moreover, the PCL fibers with different sizes and shapes (straight and wavy) were used 
to quantitatively analyze cell adhesion, proliferation, and differentiation. Our first experiment 
showed that 5 μm had the most cell adhesion, 5 μm, straight 20 μm, and wavy 35 μm provided a 
significantly better condition for the glial differentiation compared to control. More cell 
proliferation was observed on the wavy 35 μm fibers than on straight 35 μm fibers, showing that 
fiber morphology may have an effect on cell proliferation. However, this study’s goals were to 
perform two more experiments in order to have more reliable results.  
In chapter five, we used a microfluidic approach and photopolymerization strategy to 
fabricate PEGDA spherical particles as well as bow tie-shaped fibers. In this work, we showed 
that with immiscible and miscible fluids, spherical microparticles and bow tie shaped fibers can 
be fabricated using PEGDA. The flow rate ratio between the core and sheath fluids is found an 
important parameter to accurately tune the diameter of the particles as well as cross-section and 
size of the fibers. Glucose, sucrose, collagen, gelatin, PEG, and PVA were incorporated into the 
PEGDA fibers to study the porosity of the resulting fibers. It was found that sucrose and PVA can 
create porosity on the surface of the fibers after soaking the fibers in water for 6 days at 37 °C. 
The tensile properties of the PEGDA fibers with different characteristics were tested. It was found 
xvi 
 
 
that when the core flow rate increases, the resulting fibers become more stiff and brittle, which 
might be due to the increase of the cross-linking density. The mechanical properties of the 
PEGDA/collagen drop due to the low strength of the collagen, which is a natural polymer. On the 
other hand, the incorporation of glucose could improve the tensile properties of PEGDA fibers. In 
addition, we encapsulated the AHPCs into the PEGDA fibers in order to create a cell-laden fiber. 
Propidium Iodide (PI) was used for the cell viability, and the results showed that the cells could 
not survive. We believe that another hydrogel or the same polymer with higher molecular weight 
needs to be used in order to increase the cell survival into the hydrogel network. 
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CHAPTER I 
 INTRODUCTION: MICROFIBER FABRICATION 
 
1.1 Common Fiber Fabrications Methods 
Fiber systems are becoming increasingly important for numerous biological applications, 
such as tissue engineering, since the fibers are able to guide cell growth, alignment, and migration 
[1, 2]. Additionally, the design of microfibers gives them the correct properties in order to perform 
drug delivery and drug release in the human body for medical purposes [3, 4]. The fibers have high 
surface area-to-volume and strength-to-weight ratios. Some of them are permeable and can be 
woven into textiles [5]. These properties allow microfibers to carry even delicate materials, such 
as water-soluble drugs, throughout a biological medium with good accuracy [6, 7]. This makes for 
safe insertion and transmittance of material used for treatment, demonstrating the effectiveness of 
microfibers in medicine. The method of generation of the microfibers plays a role in determining 
its viability in these types of applications. 
Several approaches exist for the fabrication of microfibers from naturally derived or 
synthetic materials, such as: the microfluidic method, electrospinning, wetspinning, biospining, 
meltspinning, and rotary spinning [8]. Figure 1.1 shows a schematic of the common fiber 
fabrication approaches. In electrospinning, the flow of a viscoelastic polymer subjected to an 
electric field between an injecting needle and a collector is applied to create fibers. This method is 
relatively simple and it is feasible to efficiently scale-up and control the involved parameters such 
as flow rate and voltage. However, there are some difficulties in the fabrication of thick, complex 
3D scaffolds with this method [2, 9]. Additionally, electrospun microfibers are generally not easy 
to align and it requires extra care to ensure that the fibers are accurately aligned, especially because 
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the randomly aligned fibers are not desirable for applications like growing nerve cells [10].  
Wetspinning, on the other hand, does not rely on electricity to solidify the fiber. A pre-polymer 
solution is injected into a coagulation bath that must be either a poor solvent or a non-solvent with 
respect to the polymer. Wetspinning is an efficient method for fabricating fibers with a wide range 
of diameters by changing the diameter of the needle(s). Nevertheless, long exposure to chemicals 
during the fabrication process is required, which can be harmful to cells [11].  
The Biospinning method is a process in which silk fibers are fabricated by insects. Silk has 
high tensile strength and is biodegradable. In addition, after chemical processing, it is non-
cytotoxic and non-inflammatory. The major challenges of using biospun fibers are the limitation 
of resources, which makes it difficult for the scale-up process, as well as the fact that the process 
of silk fiber fabrication is time consuming [12]. The meltspinning approach also creates a fiber 
that has high mechanical proberties, and various synthetic polymers can be used for fiber 
fabrication. However, the meltspinning process is in a high temperature range (150 - 300 ˚C) and 
requires using expensive equipment. Using high temperatures during the fiber fabrication process 
prevents the cell or protein from being loaded onto the fiber in order to deliver the bioactive 
molecules in biomedical applications [13]. Additionally, because the viscosity of the melted 
polymer is relatively high, a high pressure difference is needed to move the melted polymer 
through the spinneret [14, 15]. Pressure is also important in rotary spinning, since the solution is 
spun at the high speeds to increase the centrifugal force, which causes the solvent to evaporate, 
resulting in fibers [16]. 
Using microfluidics to fabricate fiber is a relatively new approach in which the fiber is 
created in a microchannel using coaxial flow of core (pre-polymer) and sheath fluids. The key 
benefits of using this method include versatility of size, continuity of the fiber fabrication process, 
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and simplicity of cell, protein or drug incorporation. This process is straightforward, cost-efficient, 
reproducible, and suitable for many biological applications since the fiber is created without using 
high temperature, high pressure, high voltages, or toxic materials. 
 
 
Figure 1.1 Different methods used to fabricate polymeric fibers [17]. (a) Illustration depicting the 
encapsulation of macromolecules in a microfiber. (b) Schematic of the microfluidic fabrication of 
fibers. The manner in which the sheath and the core fluid flows are directed by micro channels to 
generate the fiber is depicted [18]. (c) For the electrospinning method, the viscoelastic polymer is 
subjected to an electric field [19]. (d) In the wet spinning process, the fibers are extruded to a 
coagulation bath [8]. (e) For the biospinning approach, the silk fibers are fabricated by insects 
[12]. (f) When meltspinning a microfiber, the polymer is heated to its melting point. Then, the 
melted polymer is extruded through a spinneret [13]. (g) In the rotary spinning method, the 
solution is spun at the high speeds at which  the centrifugal force causes the solvent to evaporate, 
resulting in fibers [16].  
 
1.2 Fiber Solidification Strategies in Microfluidic Approach 
There are physical and chemical methods used to solidify the prepolymer solution in a 
microchannel. Solvent extraction (casting) is the most common physical method, while the 
chemical solidification methods offer more variety of polymerization and cross-linking processes 
[20].   
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1.2.1 Solvent extraction (casting) method 
The phase inversion process is the simplest solidification strategy since there is no need for 
a chemical reaction or cross-linking [2, 21, 22]. In this process, two fluids, i.e. core and sheath 
fluids, are introduced into the channel. After the two fluids merge in the channel, a coaxial flow is 
created. At the fluid/fluid interface, the exchange of polymer solvent and the sheath fluid occurs 
and the polymer is solidified in the outlet of the microchannel. This strategy has been used in many 
fiber fabrication studies [1, 2, 21-24]. Figure 1.2 shows a schematic of the casting method as well 
as SEM images of some fibers fabricated by this approach. 
 
 
Figure 1.2 Microfibers fabricated using solvent extraction strategy [20]. (a and b)  Schematic of 
using the casting mechanism in microfluidic fiber fabrication and the resulting fiber [21]. (c) 
PMMA fiber fabrication. The wrinkling is due to evaporation gradient during the process [22]. 
(d) The cross section of PLGA microfibers. Three different areas are distinguishable because the 
rate of solvent extraction was not uniform [2].    
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1.2.2 Chemical cross-linking method 
In this strategy, small molecules or ions are used in order to facilitate the fiber solidification 
in the channel. The most common polymers used in this method are alginate [25-29], PLGA [2, 
30, 31], and chitosan [32, 33]. Calcium chloride (CaCl2) is one of the common cross-linking agents 
used in the sheath fluid to solidify the polymer at the outlet of the channel. Figure 1.3 shows 
images of different fibers fabricated using the chemical cross-linking method.  
 
 
Figure 1.3 Fibers made by using chemical cross-linking method [20]. (a) Hollow calcium 
alginate/poly(L-lysine) microtubes and cell-laden calcium alginate/poly(L-lysine) microfibers. (b 
and c) Fabrication of calcium alginate microfibers. (d) Encapsulation of viable (green) and dead 
(red) HepG2 cells inside Chitosan-alginate microfibers. (e) Gelatin-hydroxyphenylpropionic acid 
(Gel-HPA) microfibers cultured with Madlin-Darby canine kidney cells. (f) Alginate/Gel-HPA 
microfibers cross-linked by hydrogen peroxide.  
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1.2.3 Photopolymerization method 
In this method, free-radical polymerization reactions are used to solidify the prepolymer in 
the channel. The advantage of this method is the rapid solidification rate of the polymers in the 
channel. This method has been used to fabricate fibers with various materials and chemistries [34-
38].  
 
 
Figure 1.4 Using photopolymerization strategy to fabricate microfluidic spun fibers [20]. (a and 
b) Schematic of photopolymerization process and the resulting continuous fibers [39]. (c) Fiber 
with anisotropic porosity [40]. (d) Hollow fiber with multiple core region [41]. (e) Crimpled 
microfibers [42]. (f) H-shape fibers [35].   
 
The common materials used in this method are methacrylates [34, 36], polyurethanes, 
immiscible combinations of hexadecane and polyethylene glycol diacrylate [43], and thiol-enes 
and thiolynes [5, 35]. Because the photopolymerization occurs in fraction of second, it is feasible 
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to fabricate fiber with noncircular cross-sections [5, 34, 35]. Figure 1.4 displays a schematic of 
fiber fabrication using photopolymerization strategy and some of the resulting fibers.  
Although casting and chemical cross-linking process have some limitations and difficulties 
associated with the rate of solidification and shape formation of the fiber, they are desirable for 
biomedical applications and most of the fibers are biocompatible and biodegradable.  
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CHAPTER 2 
MECHANICAL AND PHYSICAL PROPERTIES OF DEGRADABLE POLY(VINYL 
ALCOHOL) MICROFIBERS FABRICATED BY MICROFLUIDIC APPROACH 1 
 
ABSTRACT 
A microfluidic platform was used to fabricate continuous and non-rounded polyvinyl 
alcohol (PVA) microfibers. We showed that the size and cross-section of the PVA fibers can be 
controlled by changing the PVA concentration in dimethyl sulfoxide (DMSO) and flow rate ratio 
between the core and sheath fluids. The PVA concentration was varied from 6% to 12%, and the 
sheath-to-core flow rate ratio used for this study was in the range of 500 : 5 to 500 : 20. The aspect 
ratio of the fibers became larger when the PVA concentration increased and the flow rate ratio 
decreased. Additionally, we simulated the microfluidic fiber fabrication process and the results 
were consistent with the experimental results. The dissolution of the PVA fibers fabricated with 
different characteristics was also studied. It was shown that increasing the PVA concentration and 
decreasing the flow rate ratio increased the dissolution time of the fibers in DI water. A tensile test 
                                                 
1 F. Sharifi, Z. Bai, R. Montazami, and N. Hashemi, "Mechanical and Physical Properties of Poly(vinyl alcohol) 
Microfibers Fabricated by Microfluidic Approach" RSC Advances, 6, 55343-55353 (2016). 
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was conducted to obtain the stress–strain curves for different types of fibers. The results showed 
that a wide range of mechanical properties can be achieved by changing the PVA concentration 
and the flow rate ratio. The increase of PVA concentration from 6% to 12% enhanced the tensile 
stress at break and Young's modulus by a factor of 4.9 and 2.02, respectively. The mechanical 
strength of the fibers was shown to drop when the flow rate ratio decreased. 
 
2.1 Introduction 
Nowadays, polymeric fibers are attracting more and more attention due to their remarkable 
characteristics such as extremely large surface area to volume ratio, flexibility in surface 
functionalities, and superior mechanical performance (e.g., stiffness and tensile strength) 
compared with any other known form of the material [1-4]. These outstanding properties make the 
polymer fibers optimal candidates for many important applications such as tissue engineering, cell 
encapsulation, wound dressings, and drug release [5-9].  
Several different fiber fabrication approaches exist such as microfluidic, electrospinning, 
and wet spinning [10, 11]. Microfluidics is an emerging approach that uses small amount of 
samples for a wide range of applications from biomedical systems to energy devices [12-15]. The 
microfluidic method is a simple, rapid, and low-cost method for producing fibers, which depends 
on a number of experimental parameters. Additionally, this approach does not need high 
temperature, voltage, or pressure, which can damage the living systems in the biomedical 
applications [16-18]. The shape of the resulting fiber is a function of the flow rates and the types 
and numbers of shaping elements in the channel walls such as various chevron grooves [19-21]. 
Presently, great efforts have been devoted to expand the variety of materials that can be applied to 
fabricate various types of structures using microfluidics. For instance, Thangawng et al. produced 
13 
 
round PMMA fibers with diameters down to 300 nm by varying the ratio between the sheath and 
core flow rates using a 5-diagonal groove device. Ribbon-shaped fibers with submicron thickness 
were also fabricated using a 7-chevron/5-diagonal groove combination device [22]. Recently, our 
group successfully fabricated uniform polycaprolactone (PCL) and gelatin microfibers via phase 
inversion solidification process [16]. We showed that various morphologies and cross-sections 
(round, square and ribbon) can be obtained by varying the PCL and gelatin concentrations in the 
core solution and the sheath-to-core flow rate ratio. It is expected that this strategy can be applied 
to fabricate various fibers. 
Poly(vinyl alcohol) (PVA) is a nontoxic, biocompatible, hydrophilic synthetic polymer 
with good chemical, thermal, and mechanical stability. It also possesses a wide range of 
crystallinity. Recently, it was found that PVA can be used for transient electronics and 
bioelectronics [23, 24]. Previously, PVA microfibers were fabricated using an electrospinning 
approach [25-27]. However, using electrospinning method to fabricate fibers has some 
disadvantages. The electro-spun fibers are fabricated with only round cross-sections due to the 
surface tension between the polymer and air during formation. It is also hard to accurately align 
the electro-spun fibers. The fiber characteristics, such as diameter and surface properties, do not 
vary widely. The current PVA fibers, on the other hand, are not necessarily rounded. They can be 
fabricated with different aspect ratios by simply changing different parameters such as the flow 
rate ratio between two fluids. We showed that the non-rounded fibers results in variations in 
mechanical properties and increasing the surface area-to-volume ratio of the fibers which is 
important in applications such as tissue engineering and biosensors. Moreover, the microfluidic 
platform can be considered as an alternative approach to precisely control the fiber alignment. In 
fact, this alignment is not limited to the position of one fiber with respect to others. The 
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microfluidic approach makes it feasible to align the polymer chain of each fiber due to the shear 
force exerted on the pre-polymer solution from the sheath fluid in the flow direction. The aligned 
fibrous scaffold can significantly guide the growth direction of the cells, which is useful in 
regenerating nerve tissues, blood vessels, tendons, and muscle tissue. We demonstrated that the 
size and surface properties of microfluidic-spun PVA fibers can be easily tuned by simply 
changing the 3D hydrodynamic focusing force exerted on the core fluid. In addition, the current 
PVA fibers made in this study can be used to encapsulate cells for some biomedical applications 
such as cell delivery, whereas high voltage used in electrospinning method could be harmful for 
the cells. Despite its advantages, the production rate in microfluidic approach is slower than that 
of the electrospinning. This is a result of advances in the electrospinning technique brought about 
during several decades of industrial use. Microfluidic approach, on the other hand, is a new method 
that has shown promising potential for various biomedical applications, but it may take more time 
for this method to be fully understood and more well-known [16, 28-32].  
PVA has been used in microfluidic fiber fabrication process before by Jeong et al. [33] 
However, in that study, fiber was made of 4-hydroxybutyl acrylate (4HBA), and PVA solution 
(PVA in DI water) was applied as a non-polymerizable fluid (sheath fluid) to adjust the shape of 
the fiber. In the present work, we fabricated PVA fibers using a microfluidic approach for the first 
time. We showed that the size, shape, dissolution, and mechanical properties of PVA microfluidic-
spun fibers can be tuned by changing the PVA concentration and flow rate between the core and 
sheath fluids. In addition, the microfluidic fiber fabrication process was simulated using COMSOL 
Multiphysics to study the effect of flow rate ratio on the shape of the resulting fiber. 
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2.2 Experimental Section 
2.2.1 Chemicals and materials 
Poly(vinyl alcohol) (PVA) (Mw: 61 000 g mol−1, 98.0–98.8 mol% hydrolysis) and absolute 
ethanol were purchased from Sigma-Aldrich. Dimethyl sulfoxide (DMSO) was purchased from 
Fisher Scientific. The Sylgard 184 Elastomer Base and Curing Agents were purchased from Dow 
Corning Corporation, Midland, MI. 
 
2.2.2 Microfluidic channel device design 
 A poly(methyl methacrylate) (PDMS) channel was used in this study, which is a 
transparent and biocompatible elastomer. In order to make the channel, the Sylgard 184 Elastomer 
Base and Curing Agents (PDMS pre-polymers) in a 10 : 1 ratio were stirred and poured onto two 
molds made of a SU8 photoresist-patterned silicon wafer, and cured at 80 °C for 20 min. Then the 
PDMS layers were peeled off and one of them was punched to create a connection between the 
inlet of the channel and the syringes which include the core and sheath solutions. Finally, the 
plasma treatment was applied to bond the two PDMS layers together. The microchannel is 
symmetric with one inlet for the core fluid, two inlets for the sheath fluid, and four chevron 
grooves. The dimensions of the channel are 130 μm × 390 μm (height × width). The height and 
width of the grooves are 100 μm and 65 μm, respectively, and their angle with respect to the main 
direction of the flow is 45 degrees. 
 
2.2.3 PVA fiber fabrication 
In order to prepare the core solution, 25 mL of DMSO was heated to 120 °C within 20 
min, and then PVA powders were added into the DMSO under vigorous stirring. After stirring for 
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2 hours, the mixture was cooled to room temperature. This process was repeated to prepare the 
core solutions with the PVA concentration in the range of 6–12 wt%. Absolute ethanol was applied 
as sheath fluid in this study. The core and sheath fluids were introduced into the channel using the 
3 mL and 60 mL plastic syringes (BD Biosciences) for the core and sheath fluids, respectively, 
through a double syringe pump (Cole-Parmer, Veron Hillss, IL). The flow rates of the core fluid 
were in the range of 5–50 μL min−1, whereas the constant flow rate of 500 μL min−1 was used for 
the sheath fluid. 
 
2.2.4 Computational model 
The microfluidic fiber fabrication process was simulated using the COMSOL Multiphysics 
(COMSOL, Inc., Burlington, MA) software. The purpose of the simulation was to study the effect 
of various flow rate ratios between the core and sheath fluids on the fiber shape and compare the 
numerical and experimental results. It was assumed that the process is steady-state at room 
temperature, and the fluids are incompressible. The flow and diffusion modules were coupled in 
COMSOL in order to achieve the concentration distribution of the core and sheath fluids, and to 
estimate the cross-section of the resulting fibers at the outlet. First, the velocity and pressure 
distributions were found for the channel, and then, the results were used to obtain the concentration 
profile of the fluids along the channel as well as the outlet. 
 
2.2.5 Characterization 
The viscosities of core solutions with different PVA concentrations were measured using 
a digital viscometer (DV-E, Brookfield Engineering Laboratories, Inc., Middleboro, MA). The 
size, shape, and morphology of the PVA microfibers were studied using field emission scanning 
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electron microscopy (FE-SEM) (JSM-6700F) at an acceleration voltage of 5 kV. In order to obtain 
the cross-sectional SEM images, the fibers were cut with a sharp razor. The dissolution of fibers 
were measured using UV-Vis spectrometer (PerkinElmer Lambda 25). In this part, the non-
fluorescent blue dye (105002 Standard Blue Powder, Bright Dyes) with the absorbance 
wavelength of 630 nm was used in the core fluid. After calibration, the dissolution rates of the 
fibers with different characteristics in DI water were calculated. The tensile test was performed 
with an Instron Universal Testing machine (Model 5569, Instron Engineering Corp., Canton, MA) 
at an extension rate of 50 mm min−1using a 2 kN load cell. For each test, one single fiber was 
attached on a paper frame in order to be gripped tightly by the Instron machine. The samples were 
prepared such that the distance between the two clamps is 20 mm at the beginning. Before starting 
the test, the two sides of the frame were cut to obtain the stress–strain curve of the fibers without 
the effects of the paper frame. The Bluehill software was used to control the Instron machine and 
get the results of the test. 
 
2.3 Results and Discussion 
2.3.1 Microfluidic fiber fabrication 
The fabrication method for PVA microfibers utilizing a microfluidic device is shown in 
Figure 2.1 (a). Both of the fluids, i.e. the core and sheath fluids, are introduced into the channel 
using silicone tubing. The channel has three inlets, one for the core fluid at the center and two for 
the sheath fluid.  
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Figure 2.1 (a) Schematic of the experimental setup used for microfluidic fiber fabrication. (b) 
Phase inversion solidification strategy applied to fabricate the microfluidic-spun PVA fibers. (c) 
Replacement of DMSO molecules with ethanol at the core/sheath interface, which results in 
aggregation and precipitation of PVA as a fiber. 
 
As shown in Figure 2.1 (b), we employed the phase inversion process to solidify the 
poly(vinyl alcohol) (PVA). In this process, dimethyl sulfoxide (DMSO), the solvent of PVA, is 
replaced by the sheath fluid, i.e. ethanol, at the interface between the core and sheath fluids 
(Figure 2.1 (c)).  
The PVA solidifies because the ethanol is miscible with DMSO and it does not dissolve 
the PVA. In the microfluidic channel, the lateral hydrodynamic focusing force from the sheath 
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fluid compresses the core into a thin vertical strip, which results in increased height of the core 
fluid in the channel. At the same time, because of the laminar flow regime, diffusion takes place 
at the core/sheath fluid interface and the PVA stream rapidly solidifies as a result of the phase 
inversion process. Additionally, the channel consists of four chevron grooves at the downstream 
of the channel. Once the two fluids reach this area, the sheath fluid fills the chevron grooves due 
to the fact that the hydrodynamic resistance is inversely proportional to the flow rate. As a result, 
the sheath fluid compresses the core fluid perpendicular to the main flow direction [34, 35]. These 
vertical and lateral forces on the core fluid originate from the shear force between the core and 
sheath fluids due to the velocity difference at the fluid/fluid interface, which results in aligning the 
polymer chain in the direction of the flow. 
 
2.3.2 Effect of PVA concentration   
One of the important parameters which plays a significant role on the resulting fiber is the 
concentration of PVA in the core fluid. Figure 2.2 shows the viscosity of the core solution as a 
function of PVA concentration. Based on this figure, when the PVA concentration increases from 
6% to 12%, the viscosity of the core fluid rises from 78 to 297 cP. This shows the feasibility of 
microfluidic fiber fabrication in a wide range of viscosities.  
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Figure 2.2 Viscosity of core solution prepared by various PVA concentrations in DMSO. 
 
The scanning electron microscopic (SEM) images of the fibers fabricated using different 
PVA concentrations are shown in Figure 2.3. For this part, the flow rates of the core and sheath 
fluids were kept constant at 500 μL min−1 and 5 μL min−1, respectively. Figure 2.3 (a1-c1) 
demonstrates that the average diameter of the fibers increases with the increase of the PVA 
concentration in core fluid. That is because a fixed amount of core fluid will be in the 
microchannel in a steady state condition when the core flow rate is constant. Thus, a more 
concentrated core fluid results in a larger fiber being fabricated during the phase inversion 
process in the channel. However, due to the fact that the microchannel has a rectangular cross-
section and the shape of the fiber varies based on the flow rate ratio between the core and sheath 
fluids, the resulting fibers will have different cross-sections.  
78
108
174
297
6 8 10 12
0
50
100
150
200
250
300
V
is
co
si
ty
 (c
P
)
PVA Concentration (%)
21 
 
 
 
Figure 2.3 Longitudinal (a1–c1) and cross-sectional (a2–c2) SEM images of PVA microfibers 
fabricated by PVA concentrations of (a) 6%, (b) 8%, and (c) 10% in DMSO solution. (d) Width 
and height of the fibers made by different PVA concentrations (%). The sheath and core flow rates 
were set as 500 μL min−1 and 5 μL min−1, respectively. 
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Therefore, it is more accurate to study the size and shape of the fibers using the cross-
sectional images (Figure 2.3 (a2-c2)). The results show that the ribbon shape PVA fibers can be 
fabricated through the hydrodynamic focusing process. The width and height of the PVA fibers 
made by 6%, 8%, and 10% PVA are summarized in Figure 2.3 (d). These figures clearly illustrate 
the effects of both lateral and vertical forces exerted on the core fluid from the sheath fluid. 
Regarding the lateral force, when higher concentration of PVA is used, the core fluid covers more 
space of the channel due to the higher amount of PVA in DMSO. This leads to development of 
the fiber in a lateral direction from 13.9 μm to 26.8 μm. On the other hand, the magnitude of the 
vertical force is mostly dependent on the shape and height of the chevrons, which have not been 
changed during this study. As a result, the height of the PVA microfibers does not change 
significantly. When the PVA concentration increases from 6% to 8%, the width of the fiber rises, 
whereas its height decreases such that the aspect ratio increases by a factor of 1.84. This reveals 
the importance of the PVA concentration in the shape and size of the fiber. 
 
2.3.3 Effect of flow-rate ratio between the sheath and core fluids 
Using different flow rate ratios for the core and sheath fluids results in the changes of the 
shear force at the fluid/fluid interface. Therefore, the flow rate ratio between the core and sheath 
fluids plays a pivotal role in the shape and morphology of the resulting microfibers. In this section, 
we used the flow rate ratios in the range of 25–100. We could not use lower flow rate ratios because 
the resulting shear force from the sheath fluid would not be enough to hydrodynamically focus the 
core fluid in the vertical and lateral directions, which would result in clogging of the channel. 
Figure 2.4 shows the SEM images of the fibers fabricated using the sheath-to-core flow 
rates of 500 : 5, 500 : 10, and 500 : 20, respectively. In the previous section, it was shown that by 
using the sheath-to-core flow rate of 500 : 5 and PVA concentration in the range of 6–10%, a 
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continuous and uniform fiber can be fabricated. However, it was observed that when the PVA 
concentration increases to 12% and the sheath-to-core flow rate ratio is kept at 500 : 5 μL min−1, 
the large viscosity mismatch between the core and sheath fluid leads to the fabrication of a non-
uniform fiber (Figure 2.4 (a1 and a2)). However, Figure 2.4 (a1-c1) demonstrates that the non-
uniformity of the fibers at the PVA concentration of 12% can be improved by decreasing the 
sheath-to-core flow rate ratio from 500 : 5 to 500 : 10 and 500 : 20. The reason for this behavior is 
that when the PVA concentration increases to 12%, the viscosity contrast between the core and 
sheath fluids becomes larger. Therefore, the shear force between the core and sheath fluid exceeds 
the stable flow regime, which is the reason for the two viscous fluids to experience instability. To 
avoid this issue, we reduced the flow rate ratio between the two fluids in order to decrease the 
shear force at the core/sheath interface.  
This reveals that the shape and morphology of the fibers are dependent on the flow rate 
ratio between the core and sheath fluids as well as the PVA concentration in the core solution. 
Furthermore, the cross-sectional SEM images of the fibers are shown in Figure 2.4 (a2 - c2). The 
width and height of the PVA fibers fabricated by the PVA concentration of 12% and different 
sheath-to-core flow rates of 500 : 5, 500 : 10, and 500 : 20 are provided in Figure 2.4 (d). The 
results demonstrate that the average width and height of the fiber at the sheath-to-core flow rate of 
500 : 5 are 14.6 μm and 8.6 μm, respectively. The decrease of the flow rate ratio weakens the shear 
force of the sheath fluid on the core fluid because the relative velocity at the fluid/fluid interface 
reduces. Therefore, the core fluid develops in the microchannel such that the width of the resulting 
fiber increases by 45% at the flow rate ratio of 500 : 20, while the width of the channel negligibly 
varies.  
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Figure 2.4 Longitudinal (a1–c1) and cross-sectional (a2–c2) SEM images of PVA microfibers 
fabricated by the PVA concentration of 12% in DMSO and the sheath-to-core flow-rate ratios of 
(a) 500 : 5, (b) 500 : 10 and (c) 500 : 20. (d) Width and height of the fibers made by different flow 
rate ratios and 12% PVA concentration. 
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Apart from the experimental work, the microfluidic fiber fabrication process was simulated 
using COMSOL multiphysics. For the simulation, one fourth of the microchannel was modeled 
due to the symmetric geometry of the channel and boundary conditions. The Navier Stokes and 
Fick equations were applied to find the velocity and concentration, respectively. Figure 2.5 
demonstrates the concentration distribution along the channel and at the outlet. The white and 
black colors represent the core and sheath fluids, respectively. Figure 2.5 (a) clearly illustrates 
both of the lateral and vertical hydrodynamic focusing forces exerted by the sheath fluid on the 
core fluid. At the beginning of the channel, the velocity of the sheath fluid is considerably higher 
than that of the core fluid, and this velocity difference intensifies in the nozzle area. As a result, 
the core fluid is laterally focused, and it is changed to a vertical strip. After the nozzle region, the 
sequential chevron grooves play a significant role in creating the vertical force causing the shear 
force to wrap around the core fluid, such that the core fluid is placed at the center of the channel. 
In this area, the hydrodynamic resistance perpendicular to the flow direction decreases and the 
sheath fluid fills this area as the resistance is inversely proportional to the flow rate. Thus, the core 
fluid is vertically focused from top and bottom, which results in the fabrication of the ribbon-
shaped fibers. Based on these explanations, it is obvious that the values of the core and sheath flow 
rates directly affect the size and aspect ratio of the resulting fibers. For example, Figure 2.5 (b) 
and (c) shows the cross-section of the fibers at the outlet of the channel when the sheath-to-core 
flow rates are 500 : 10 and 500 : 20, respectively. As expected, the size and aspect ratio of the fiber 
increase when the flow rate ratio decreases. That is because the increase of the core flow rate 
reduces the relative velocity at the interface between the two fluids, which results in the decrease 
of the lateral shear force on the core fluid. However, the vertical force on the core fluid mostly 
depends on the height and number of the chevrons, which were kept constant in this study [35]. 
26 
 
Therefore, the width of the fiber enlarges and the height of the fiber is not directly affected by 
changing the flow rate ratio, which results in fabrication of fibers with higher aspect ratios. This 
behavior was observed in experimental results (Figure 2.4 (a2 - c2)), which shows a good 
agreement between the experimental and numerical results. 
 
 
Figure 2.5 The concentration (mol m−3) profile of the sheath and core fluids (a) along the channel 
and (b and c) at the outlet with the sheath-to-core flow rates of 500 : 10 and 500 : 20, respectively. 
The white color represents the core fluid and the sheath fluid is black in this study. 
 
2.3.4 Characterization of the PVA fibers  
The dissolution of the fibers with different characteristics was measured using UV-Vis 
spectroscopy and the results are shown in Figure 2.6. This method was selected because the weight 
of the fibers is very low and the dissolution of PVA is relatively fast. Therefore, the conventional 
methods, such as weighing the sample at different times, are not accurate for measuring the 
dissolution of the fibers. However, because PVA does not have any UV-Vis absorption band, we 
dyed the fibers with a blue color, which gives a peak at the wavelength of 630 nm. As an example, 
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the result of UV-Vis spectroscopy for the dissolution of the fiber fabricated using 12% PVA with 
the flow rate ratio of 500 : 5 is illustrated in Figure 2.6 (a). The results show that the peak at the 
wavelength of 630 nm intensifies with time, which represents the dissolving of the PVA fiber in 
DI water. As expected, this figure demonstrates that the dissolution of the PVA fibers is fast. The 
speed of dissolution can be attributed to the fact that the hydroxyl groups in PVA create hydrogen-
bonding with the molecules of highly polar solvents, such as water. This work was conducted for 
fibers fabricated with various PVA concentrations and flow rate ratios, and the results are provided 
in Figure 2.6 (b).  
 
 
Figure 2.6 Dissolution of the PVA fibers in DI water. (a) UV-Vis absorption spectra of dyed fiber 
with the PVA concentration of 12% in water at different times. (b) Dissolution of PVA microfibers 
fabricated by various PVA concentrations and flow-rates in water. 
 
Based on this figure, the increase of the PVA concentration increases the dissolution time 
of the PVA fibers. That is expected because when the core flow rate is set at 5 μL min−1, the volume 
of the core fluid that occupies part of the channel is constant. Therefore, a more concentrated core 
solution gives a higher amount of PVA in the channel, which results in fabrication of larger fibers 
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that take a longer time to be dissolved in water. Additionally, the decrease of the flow rate ratio 
between the core and sheath fluids reduces the hydrodynamic focusing force, and the average size 
of the fiber becomes larger. This causes the PVA fiber to last longer in water.  
The mechanical properties of biomaterials are important aspects in different biomedical 
applications such as tissue engineering. One of the goals of using scaffolds is to be able to mimic 
the mechanical properties of the tissue or organ. Figure 2.7 shows the results of conducting a 
tensile test for the fibers created with different PVA concentrations and flow rate ratios. 
Additionally, the values of the tensile stress at break (MPa), tensile strain at break (%), and Young's 
modulus (MPa) are listed in Table 2.1. When the PVA concentration is 6% and the flow rate ratio 
between the sheath and core fluids is 500 : 5, the tensile stress at break, Young's modulus, and 
tensile strain at break (%) are 8.3 MPa, 2112.9 MPa, and 3.35, respectively. By increasing the 
PVA concentration to 12%, the tensile stress at break and Young's modulus are significantly 
enhanced by 390% and 102%, respectively. Similarly, the tensile strain at break (%) improves by 
increasing the PVA concentration to 10%. However, it reduces with further increase in the PVA 
concentration. All of the measurements were done at room temperature (below the glass transition 
temperature of the PVA at 85 °C), which results in low tensile strain at break for all types of the 
PVA fibers. In addition, when the flow rate ratio between the core and sheath fluids decreases 
from 500 : 5 to 500 : 20, the tensile stress at break, tensile strain at break, and Young's modulus 
drop by a factor of 1.76, 1.77, and 4.25, respectively. This can be due to the change of the cross-
section of the fiber. As shown in Figure 2.4, when the flow rate ratio decreases, the aspect ratio 
of the fiber increases and the ribbon shape fiber is fabricated. In ribbon shape fibers, one side of 
the cross-section of the fiber is smaller than the other one. Therefore, when the fiber is under the 
tensile load and the cross-section of the sample decreases, the smaller side is weaker, which leads 
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to sample failure in lower loads and strains. This kind of behavior was observed for the thiol-ene 
and thiol-yne click fibers as well [28]. Nevertheless, the surface area of the ribbon shape fibers is 
larger than that of the square fibers, which is an important aspect for fibrous scaffolds to support 
the growth of more cells in tissue engineering. 
 
 
Figure 2.7 Tensile properties of PVA fibers fabricated with (a) the flow rate ratio of 500 : 5 for 
the sheath:core fluids and various PVA concentrations in DMSO. (b) PVA concentration of 12% 
and different flow rate ratios. 
 
Table 2.1 Mechanical properties of the fibers fabricated with various concentrations of PVA in 
DMSO and flow rate ratios between the core and sheath fluids. 
PVA 
Concentration (%) 
Flow Rate Ratio 
(Sheath:Core) 
Tensile Stress 
at Break (MPa)
Tensile Strain 
at Break (%) 
Young’s 
Modulus (MPa)
6 500:5 8.30 3.35 2112.9 
8 500:5 14.83 3.61 2251.7 
12 500:5 40.71 2.94 4265.1 
12 500:10 37.81 1.29 3261.5 
12 500:20 23.15 1.66 1003.4 
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There are some studies in which PVA fibers were fabricated using electrospinning method 
[36-39]. However, there is no report about the mechanical properties of single electrospun PVA 
fibers. In fact, it is common to measure the mechanical properties of the fibrous mats instead in 
this method. After comparing the results of this study with those reported for electrospun PVA 
mats, it was found that the microfluidic spun PVA fibers have a higher tensile stress at break and 
Young's modulus, but lower tensile strain at break. The reason for higher tensile stress might be 
due to the fact that the shear force exerted on the prepolymer solution align the polymer chain in 
the flow direction. It was expected to obtain lower strain (%) compared to the electrospun PVA 
mats because multiple fibers support each other and cause the mats to break at higher strain. In 
addition, higher strain of PVA mats can be due to the fact that the electrospun fibers are made 
randomly and most of them are not in the same direction as the tensile test. Consequently, they 
will break at higher strain. 
Apart from fibrous mats, there are some reports that the mechanical properties of PVA 
films were measured [23, 40-47]. It was found that the values of tensile stress at break and Young's 
modulus are comparable with the ones reported in the literature for the PVA films. However, the 
tensile strain at break of the PVA films is larger. That might be related to the fabrication process. 
In this paper, the phase inversion solidification strategy was used to fabricate fiber. This strategy 
caused the molecules of DMSO and ethanol to be replaced which creates a porous fiber, whereas 
the PVA films made by different methods have lower porosity. Additionally, when a defect occurs 
in both PVA fiber and film, it propagates until the sample breaks. Because the average cross 
section area of the films is significantly larger than that of the fibers, the defect has to propagate 
more to completely break the sample, which results in higher strain at break (%) for the film. 
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2.4 Conclusions 
The PVA microfiber was fabricated using a microfluidic approach. The effects of PVA 
concentration in the core fluid and flow rate ratio between the core and sheath fluid were 
investigated. The size, cross-section, dissolution of the fiber in DI water, as well as the mechanical 
properties of the fibers, were studied. It was found that when a higher PVA concentration is used, 
the size of the fiber increases, the dissolution of the fiber in water takes more time, and the 
mechanical properties are improved. When the PVA concentration increases from 6% to 12%, the 
tensile stress at break and Young's modulus are enhanced by 390% and 102%, respectively. On 
the other hand, when the flow rate ratio between the core and sheath fluids decreases, the size and 
aspect ratio of the fiber become larger, the fiber lasts longer in the water, and all of the tensile 
properties of the fiber drop. It was observed that the tensile stress at break, tensile strain at break, 
and Young's modulus can be enhanced by a factor of 1.76, 1.77, and 4.25 when the flow rate ratio 
increases from 25 to 100. Once again, it was proved that the microfluidic fiber fabrication is a 
promising platform to provide an accurate control on the size, shape, dissolution, and mechanical 
properties of the fibers, which could be useful in different biomedical applications. 
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CHAPTER 3 
DESIGNING HIGHLY STRUCTURED POLYCAPROLACTONE FIBERS USING 
MICROFLUIDICS 1 
 
 
ABSTRACT 
Microfibers are becoming increasingly important for biomedical applications such as 
regenerative medicine and tissue engineering. We have used a microfluidic approach to create 
polycaprolactone (PCL) microfibers in a controlled manner. Through the variations of the sheath 
fluid flow rate and PCL concentration in the core solution, the morphology of the microfibers and 
their cross-sections can be tuned. The microfibers were made using PCL concentrations of 2%, 
5%, and 8% in the core fluid with a wide range of sheath-to-core flow rate ratios from 
120:5 µL/min to 10:5 µL/min, respectively. The results revealed that the mechanical properties of 
the PCL microfibers made using microfluidic approach were significantly improved compared to 
the PCL microfibers made by other fiber fabrication methods. Additionally, it was demonstrated 
                                                 
1 F. Sharifi, D. Kurteshi, and N. Hashemi, "Designing Highly Structured Polycaprolactone Fibers using 
Microfluidics", Journal of the Mechanical Behavior of Biomedical Materials, 61, 530-540 (2016). 
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that by decreasing the flow rate ratio and increasing the PCL concentration, the size of the 
microfiber could be increased. Varying the sheath-to-core flow rate ratios from 40:5 to 10:5, the 
tensile stress at break, the tensile strain at break, and the Young׳s modulus were enhanced from 
24.51 MPa to 77.07 MPa, 567% to 1420%, and 247.25 MPa to 539.70 MPa, respectively. The 
porosity and roughness of microfiber decreased when the PCL concentration increased from 2% 
to 8%, whereas changing the flow rate ratio did not have considerable impact on the microfiber 
roughness. 
 
3.1 Introduction 
Fiber systems are becoming increasingly important for numerous biological applications, 
such as tissue engineering, as the fibers are able to guide cell growth, alignment, and migration [1, 
2]. Additionally, the design of microfibers gives them the correct properties in order to perform 
drug delivery and drug release in the human body for medical purposes [3, 4]. The fibers have high 
surface area-to-volume and strength-to-weight ratios. Some of them are permeable and can be 
woven into textiles [5]. These properties allow microfibers to carry even delicate materials, such 
as water-soluble drugs, throughout a biological medium with good accuracy [6, 7]. This makes for 
safe insertion and transmittance of material used for treatment, demonstrating the effectiveness of 
microfibers in medicine. The method of generation of the microfibers plays a role in determining 
its viability in these types of applications.  
Several approaches exist for the fabrication of microfibers from naturally derived or 
synthetic materials such as electrospinning, wetspinning, biospining, meltspinning, and the 
microfluidic techniques [8]. Electrospinning is relatively a simple method and it is feasible to 
efficiently scale-up and control the involved parameters such as flow rate and voltage. However, 
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there are some difficulties in the fabrication of thick, complex 3D scaffolds with this method [2, 
9]. Additionally, electrospun microfibers are generally not easy to align and it requires extra care 
to ensure that the fibers are accurately aligned, especially because the randomly aligned fibers are 
not desirable for applications like growing nerve cells [10]. Wetspinning is an efficient method for 
fabricating fibers with a wide range of diameters by changing the needle(s) diameter. Nevertheless, 
long exposure to chemicals during the fabrication process is required, which can be harmful to 
cells [11]. Biospinning method is the process of fabricating silk fibers by insects. Silk has high 
tensile strength and is biodegradable. In addition, after chemical processing, it is non-cytotoxic 
and non-inflammatory. The major challenges of using biospun fibers are the limitation of 
resources, which makes it difficult for the scale-up process, as well as the fact that the process of 
silk fiber fabrication is time consuming [12]. In the meltspinning approach, various synthetic 
polymers can be used for fiber fabrication with this method. Fibers created by meltspinning have 
high mechanical properties. However, the meltspinning process is in a high temperature range 
(150–300 °C) and requires using expensive equipment. Using high temperatures during the fiber 
fabrication process prevents the cell or protein from being loaded onto the fiber in order to deliver 
the bioactive molecules in biomedical applications [13]. Additionally, because the viscosity of the 
melted polymer is relatively high, a high pressure difference is needed to move the melted polymer 
through the spinneret [14, 15]. 
Using microfluidics to fabricate fiber is a relatively new approach in which the fiber is 
created in a microchannel using coaxial flow of core (pre-polymer) and sheath fluids. The key 
benefits of using this method include versatility of size, continuity of the fiber fabrication process, 
and simplicity of cell, protein or drug incorporation. This process is straightforward, cost-efficient, 
reproducible, and suitable for many biological applications since the fiber is created without using 
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high temperature, high pressure, high voltages, or toxic materials. By changing the flow rate and 
flow rate ratio, the fiber size and aspect ratio can be simply controlled [2, 16-18]. The microfluidic 
fiber fabrication can be employed to create fibers with various materials using different cross-
linking mechanisms such as photopolymerization (e.g., polyethyleneglycol diacrylate, 4-
hydroxybutyl acrylate) [19-22], ionic gelation (e.g., alginate) [23], and thermal phase transition 
(e.g., agar) [24, 25].  However, there are some studies which employ phase inversion process 
instead of cross linking method to solidify the polymer [2, 17]. used the solution of poly(lactic-co-
glycolic acid) (PLGA) in dimethyl sulfoxide (DMSO) and mixture of glycerin and distilled water 
as the core and sheath fluids, respectively [2]. At the fluid–fluid interface in the channel, the 
DMSO in the core fluid is replaced by water in the sheath fluid and the polymer is solidified. 
Likewise, Bai et al. dissolved gelatin in DMSO and showed that by exchanging the DMSO in the 
core fluid and ethanol in the sheath fluid, the gelatin can be solidified [17].  
This approach makes it feasible to fabricate fibers with different shapes of solid [16, 17, 
26], tubular [27, 28], hybrid [10], and flat [29, 30] dimensions for divergent applications such as 
cell encapsulation, alignment, and immobilization. There are different physical and chemical 
methods for solidification of fibers including diffusion-limited solidification by solvent extraction, 
diffusion-limited solidification by chemical cross-linking, and photo polymerization [31]. The 
fibers fabricated by photopolymerization are not easily degraded and metabolized in biomedical 
applications. In addition, ultraviolet radiation (UV) has damaging effects on bioactive species [32]. 
It was demonstrated by Hwang et al. that the concentration of photo-initiator has adverse impacts 
on the cell viability [33]. The negative aspects of UV-light can be minimized by decreasing the 
exposure time and using less-harmful wavelengths than the standard one [34]. Due to these 
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limitations, photopolymerization is not the most desired approach for fabrication of fibers in cell 
encapsulation applications.  
Although some thermoplastic polymers have been used in microfluidic fiber fabrication 
such as PLGA [2] and poly(methyl methacrylate) (PMMA) [35], there is no report on microfluidic 
fabrication of PCL fibers. PCL is a Food and Drug Administration (FDA) approved polymer which 
is widely used as a biomaterial due to its biocompatibility and biodegradability [36-38]. Due to 
slower degradation rate of this polymer, for instance compared to PLGA, it possesses no adverse 
impacts on cell viability and migration because it does not change the PH of the environment 
during the degradation sharply [39]. This polymer also has good mechanical properties, is not 
toxic, and its rate of degradation can be controlled. Furthermore, PCL does not trigger immune 
responses in the body [40]. 
In this paper, we have employed solvent extraction to fabricate biocompatible and 
biodegradable PCL microfibers in a microfluidic platform for the first time. PCL grants us the 
advantage of having a biocompatible and strong material from which to make fibers. Using 
microfluidics, we are able to avoid the constraints of other methods such as electrospinning [2]. 
We can produce fibers with different cross-sectional shapes while the fabrication is continuous 
and stops only when the core and sheath solutions stop flowing. By fabricating PCL using a 
microfluidic microchannel, we are benefitting from combining the properties of a proven 
biocompatible material and the unique properties of a microfluidic fabrication technique to create 
fibers for many biomedical applications such as tissue engineering and drug delivery. After 
solidification of PCL fibers, they exit the channel directly into a water bath where the sheath fluid 
is washed off. The fibers are then collected and characterized to understand their physical and 
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mechanical properties. We have also performed simulations using COMSOL multiphysics to 
compare with the experimental results. 
 
3.2 Materials 
 Polycaprolactone (Mn=80,000) and polyethylene glycol (PEG) (Mn=20,000) were obtained 
from Sigma Aldrich (St. Louis, MO). The solvent for the core solution is 2,2,2-trifluoroethanol 
(TFE), which was purchased from Oakwood Chemical (West Columbia, SC). The material used 
for the microfluidic channel is polydimethylsiloxane (PDMS). The core solution was prepared by 
pouring PCL into the TFE at different concentrations by volume (2%, 5%, and 8% PCL). The 
sheath fluid was made using a PEG concentration of 5% into a mixture of water and ethanol with 
a volume ratio of 1:1. The solutions were prepared at room temperature. The syringes used to pump 
the fluids were obtained from BD Medical (Franklin Lakes, New Jersey). The syringe pumps used 
to introduce fluids to the microchannel were purchased from Cole Parmer (Vernon Hills, Illinois). 
 
3.3 Microfluidic Approach 
Using a dual-drive syringe pump, the core and sheath fluids are simultaneously introduced 
into the microchannel. The core fluid enters the channel through the central opening and the sheath 
flow enters on each of the sides. Additionally, our microchannel contains three inlets, one in the 
middle for introducing the core flow and two on the sides for running sheath flows (Figure 3.1).  
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Figure 3.1 (a) A schematic of microfluidic fiber fabrication method. (b) Concentration pattern of 
the core fluid at different sections of the channel; the flow rate ratio of 80:5 µL/min for the sheath 
and core fluids, respectively. 
 
The shear force between the core and sheath fluids focuses the core fluid in the center of 
the microchannel hydrodynamically [41-44] and fibers are formed from the core fluid employing 
solvent extraction solidification approach. The microfluidic method enables the fabrication of 
fibers with different sizes and cross sections. The dimensions of the fiber depend on the core and 
sheath flow rates [45]. Additionally, the shear force aligns the polymer chains along the flow 
direction in the final microfiber product. Therefore, we can control the microstructures of the fibers 
and their bulk mechanical properties. Here, the phase inversion process causes the TFE in the core 
fluid to be replaced by the sheath fluid. Because PCL does not dissolve in the sheath fluid, it 
becomes solidified as a microfiber further downstream the channel.   
Figure 3.1 (a) illustrates a schematic of microfluidic fiber fabrication. The pattern of the 
core fluid at different sections of the channel is illustrated by Figure 3.1 (b). In fact, the sheath 
fluid has a lateral hydrodynamic force on the core fluid in the nozzle area. After that, the cross 
section of the channel remains constant until two fluids meet the chevrons of the channel. In this 
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region, the hydrodynamic resistance in the direction parallel to the peaks and valleys is less than 
the direction of the channel. Consequently, the component of velocity which is perpendicular to 
the channel increases for both of the fluids. The hydrodynamic resistance is inversely proportional 
to the flow rate. Therefore, the sheath fluid will experience less resistance compared to the core 
fluid since the flow rate of the sheath fluid is considerably higher than the core fluid. Sheath fluid 
wraps around the core fluid and exerts vertical hydrodynamic force towards the center of the 
channel in the chevrons region. After passing through these chevrons, the core fluid will be focused 
at the center of the channel and there will not be any contact between the core fluid and the channel 
walls. Apart from exerting hydrodynamic force, the sheath fluid plays the role of a lubricant in the 
channel to facilitate fiber extrusion. Therefore, the viscosity of the sheath fluid should be matched 
to that of the core fluid. For this purpose, polyethylene glycol (PEG) is added to the sheath fluid 
in order to increase its viscosity. Figure 3.2 shows the viscosity of core and sheath fluids at 
different concentrations of PCL and PEG (2–8%), respectively. While the range of viscosity varies 
from 19 cP to 500 cP for the core fluid, it is limited to 2–16 cP for the sheath fluid. In this study, 
we used 5% PEG in the sheath fluid and changed the concentration of the PCL in the core fluid 
from 2% to 8% in order to show the versatility of microfluidic approach in fabricating fiber using 
a wide range of core fluid viscosity. 
While the core flow rate is kept constant at 5 µL/min, the sheath flow rate varies from 
10 µL/min to 120 µL/min. Our microchannel contains three inlets, one in the middle for 
introducing the core flow and two on the sides for running sheath flows. The channel has four 
chevron grooves that create vertical hydrodynamic force. The magnitude of the hydrodynamic 
force is directly related to the flow rate ratio (velocity gradient between sheath and core fluid), 
which is an important parameter in determining the features of the fiber. 
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Figure 3.2 Viscosity of (a) the core and sheath solutions using different concentrations of PCL 
and PEG, respectively; (b) enlarged view of sheath solution viscosity made by three different 
concentrations of PEG. 
 
Downstream from the microchannel entrance, the fluid comes into contact with the chevron 
grooves, which are engrained on the top and bottom surfaces of the channel. The grooves play an 
important role in focusing the core fluid vertically and determining the final cross-sectional shape 
of the fibers. The shear stress aligns the polymer chains in the core flow in the direction of the 
flows. The solidification of core flow occurs once it comes to contact with the sheath flows. During 
the whole process, the channel is positioned vertically and the resulting fibers exit directly into a 
water bath.  
After the fibers were recovered, their characteristics were evaluated through several means. A 
scanning electron microscope (SEM) from Nikon (Tokyo, Japan) was used to determine the 
morphology of the fibers. The SEM was used to study the effects of changing the flow rate ratio 
of sheath and core fluids as well as the PCL concentration in the core solution on the morphology 
and cross section of the fabricated microfibers. In addition, the mechanical properties of the fibers 
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were measured to assess their strength. Finally, the microfluidic fiber fabrication was simulated 
using COMSOL multiphysics software in order to compare the experimental and numerical results. 
 
3.4 Characterization 
The morphology and cross section of the microfibers were studied using the field emission 
scanning electron microscopy (FE-SEM) (JSM-6700F at an acceleration voltage of 5 kV). The 
viscosities of the core and sheath solutions were measured using a digital viscometer (DV-E, 
Brookfield Engineering Laboratories, Inc., Middleboro, MA). For measuring the stress–strain 
behavior of the fibers, single fiber was tested using Instron Universal Testing machine (Model 
5569, Instron Engineering Corp., Canton, MA). For each type of the fibers, 10 samples were tested 
and the average values for each type were reported. Since the PCL fibers have high ductility, we 
used a 10 N load cell to get enough resolution, and the extension rate was set to 20 mm/min. In 
this test, the samples were prepared by attaching them on a paper frame in order to be gripped 
properly by the Instron machine. After mounting the sample on the machine, we cut two sides of 
the frame to get the mechanical properties of PCL fiber. The length of the samples for this test was 
15 mm. The results were found using Bluehill software. A video file is provided in supplementary 
materials, that shows high ductility of the fiber during the tensile test. The stress–strain curves 
were fitted with linear line for the elastic region. Second order polynomial equation was used for 
the plastic region because its coefficient of determination (R-Square) was better compared to the 
linear line for all of the data. 
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3.5 Results and Discussion 
We fabricated microfibers using 2%, 5%, and 8% PCL and 5% PEG in TFE and 
water/ethanol (with the volume ratio of 1:1), respectively. Varying the sheath and core flow rates, 
it was found that the core flow rate of 5 µL/min and the sheath flow rate of 10–120 µL/min are 
appropriate flow rates in order to obtain continuous microfiber. 
The versatility of the microfluidic fiber fabrication method can be highlighted by using 
various flow rates of sheath fluid and PCL concentrations in the core fluid. The results revealed 
that the flow rate ratio of the core and sheath fluids plays a significant role in the morphology of 
the fabricated fibers. Using a very low sheath flow rate does not allow for enough of both the 
vertical and horizontal hydrodynamic forces on the core fluid. As a result, the width of the core 
fluid increases. Also, the aggregation of the polymer becomes stronger than its elongation along 
the channel. This condition leads to occurrence of clogging in the microchannel. On the other hand, 
if the core fluid has a high flow rate, there is a possibility that the core fluid exit the channel and 
no solidification happens. Figure 3.3 shows the SEM images of the representative microfibers 
obtained using different flow rate ratios. The concentrations of PCL and PEG were kept at a 
constant value of 5% in the core and sheath fluids, respectively.  
This figure illustrates that the roughness of the surface is not significantly affected by 
changing the flow rate ratio between the fluids. However, at the higher flow rates of sheath fluid, 
the microfibers have wavy structures, and as the sheath flow rate decreases, the microfibers tend 
to be more uniform and straight. This means that the Kelvin–Helmholtz instability occurs at high 
flow rate ratios due to sharp difference of velocities at the core fluid/sheath fluid interface in the 
channel, and it leads to the creation of wavy shaped microfibers. Additionally, this figure 
demonstrates that the size of the microfibers increases when the sheath flow rate reduces.  
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Figure 3.3 SEM images of PCL microfibers with 5% PCL in TFE (core fluid) and 5% PEG in 
water and ethanol (sheath fluid) and different flow rates of (a) 120: 5 (b) 100: 5 (c) 80: 5 (d) 60: 
5 (e) 20: 5, and (f) 10: 5 µL/min for the sheath and core fluids, respectively. 
 
This is expected, because when the difference of the velocities decreases, the 
hydrodynamic shear force exerted from the sheath fluid on the core fluid weakens. Consequently, 
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the core fluid expands in the channel and the average diameter of the fiber increases. In Figure 3.4 
(a-c), the cross-sectional SEM images of the microfibers fabricated with different flow rate ratios 
are provided. This figure shows that the cross-section of the fibers made by microfluidic approach 
can be tuned by simply changing the flow rate ratio between the sheath and core fluids. 
Additionally, the dimensions of the fibers (average±standard error) are shown in Figure 3.4 (d).  
 
 
 
Figure 3.4 Cross sectional SEM images of PCL microfibers with 5% PCL in TFE (core fluid) and 
5% PEG in water and ethanol (sheath fluid) fabricated by sheath and core flow rates of (a) 120:5, 
(b) 60:5, and (c) 10:5 µL/min, respectively. (d) Dimensions of the PCL fibers fabricated using 
different sheath-to-core flow rate ratios.   
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The width and height of the PCL fiber at the sheath-to-core flow rate ratio of 120:5 are 
16.21 µm and 22.34 µm, respectively. The decrease of the flow rate ratio to 10:5 increases both 
the width and height of the fiber to 21.12 µm and 33.56 µm, respectively. Moreover, the aspect 
ratio of the fiber increases by a factor of 1.15 when the flow rate ratio reduces from 120:5 to 10:5. 
That was expected because when the flow rate ratio between two fluids diminishes, the lateral 
hydrodynamic force exerted to the core fluid by sheath fluid weakens. Consequently, the core fluid 
has more freedom to grow in the lateral direction. On the other hand, when the sheath flow rate 
increases, the shear force intensifies and the core fluid is stretched more due to the higher 
hydrodynamic force that leads to the fabrication of fibers with smaller size. 
The microfluidic fiber fabrication was simulated using COMSOL multiphysics. The 
Navier–Stokes equation for incompressible flow at steady state was used to numerically solve the 
momentum balance. Because the inertial forces are negligible at low Reynolds number, the motion 
of the fluid can be approximately described by the reversible Stokes equation in which the 
nonlinear term can be neglected. We used Fick׳s law, െ׏. ሺെD. ׏cሻ ൅ u. ׏c ൌ 0, In this equation, 
D is the diffusion coefficient and c represents the concentration. The Navier–Stokes equation was 
solved first and was then followed by the convection–diffusion relationships. Due to symmetry, 
one fourth of the channel was modeled. This figure illustrates that the velocity of two fluids 
increases by passing through the nozzle part of the channel. In the chevrons area, the component 
of velocity which is perpendicular to the channel, increases by passing the fluid through the 
chevrons. 
Figure 3.5 (a) shows the concentration distribution along the channel. The bright and dark 
colors represent the situations of core and sheath fluids, respectively along the channel. Therefore, 
the effects of lateral and vertical hydrodynamic focusing forces of the sheath fluid on the core fluid 
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can be observed clearly by following the brighter color along the channel. Additionally, the bright 
color at the output of the microchannel represents the cross sectional pattern of the microfiber 
fabricated using a specific flow rate ratio. Based on Figure 3.5 (a), the thickness of the core fluid 
reduces after the nozzle area, which reveals an increasing lateral force of the sheath fluid on the 
core fluid.  
 
 
Figure 3.5 (a) Three-dimensional concentration distribution of core fluid in sheath fluid along the 
channel; the flow rate ratio is 80:5 µL/min for the sheath and core fluids, respectively; Top view 
of the channel and the cross section of the fibers with sheath and core flow-rates of (b1) and (b2) 
120:5, (c1) and (c2) 60:5, and (d1) and (d2) 10:5 µL/min, respectively. 
 
Downstream from the initial focusing region, the series of chevrons change the 
hydrodynamic resistance in the channel such that the resistance in the perpendicular direction 
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becomes smaller than the parallel one. Figure 3.5 (a) displays that the vertical force in the chevrons 
region gradually focuses the core solution at the center of the channel. The concentration 
distribution of the core and sheath fluids are shown in Figure 3.5 (b1-d1) for different values of 
sheath flow-rate and constant value of 5 µL/min for the core flow rate. This figure illustrates a 
weakening of the hydrodynamic lateral force of the sheath fluid on the core fluid due to decreasing 
the sheath flow-rate. Consequently, the width of the fabricated fiber becomes larger. The vertical 
hydrodynamic force, however, does not change significantly due to the fact that this force is 
originated from the number of the chevrons. Therefore, the combination of a decrease in lateral 
force and a constant value of the vertical force leads to the development of the ribbon-shape 
pattern. Figure 3.5 (b2-d2) illustrates the trend in which the core cross section changes to a ribbon-
shaped pattern. These results demonstrated consistency between the experimental and numerical 
results. 
The concentration of the core fluid can be changed in microfluidic fiber fabrication as well 
as the flow rate and flow rate ratio between the sheath and core fluid in order to change the 
characteristics of microfibers. Figure 3.6 illustrates the effects of different concentrations (2%, 
5%, and 8%) of PCL in the core fluid on morphology of fibers. Increasing the PCL concentration 
results in fiber with smoother surface. Additionally, 2% PCL fibers show more porosity compared 
to the fibers made from higher PCL concentrations. When core fluid with low concentration of 
PCL is introduced into the channel, the total amount of PCL in core fluid is not enough to create a 
uniform fiber after solvent extraction and the resulting fibers become more porous. Moreover, the 
higher roughness and existence of porosity on the fiber at low concentrations of PCL is due to 
rapid exchange of TFE and sheath fluid compared to higher concentrations. While the uniform 
microfibers have higher mechanical properties, more porous microfibers can enhance cell adhesion 
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and cell proliferation, which are desirable in tissue engineering applications. Furthermore, tuning 
the porosity and microstructures of the fibers by changing the PCL concentration in the core fluid 
is another advantage of microfluidic approach. 
 
 
Figure 3.6 SEM images of PCL microfibers with 5% PEG in the sheath fluid and the PCL 
concentrations of (a1) and (a2) 2%; (b1) and (b2) 5%; and (c1) and (c2) 8% in the core fluid. Sheath 
flow rate is 60 µL/min and core flow rate is 5 µL/min. 
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The cross-sectional SEM images of PCL microfibers fabricated using different percentages 
of PCL in the core fluid are shown in Figure 3.7 (a-c). This figure demonstrates that the PCL 
concentration can influence the size of the resulting fiber as well as the flow rate ratio between the 
two fluids. Figure 3.7 (d) displays the dimensions of the fibers made by different PCL 
concentration in the core fluid.  
 
 
 
Figure 3.7 Cross sectional SEM images of PCL microfibers with different concentrations of (a) 
2%; (b) 5%; and (c) 8% PCL in the core fluid and 5% PEG in the sheath fluid with the flow rate 
of 60:5 µL/min for the sheath and core fluids, respectively. (d) Dimensions of the PCL fibers 
fabricated using different PCL concentrations in the core fluid. 
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while the aspect ratio does not change significantly. That is because when lower amount of PCL 
in the core solution flows through the channel, the dimensions of PCL solidified as a fiber during 
the phase inversion process in the microchannel will be reduced. 
The mechanical properties of the fibers made by different flow rate ratios were 
investigated. Stress–strain behavior of different fibers are shown in Figure 3.8 (a). This figure 
demonstrates a wide range of mechanical properties that can be obtained using this microfluidic 
approach. As expected from a typical plastic material, the elastic region of the PCL stress–strain 
curve is in a small range, which is shown in Figure 3.8 (b). The Young’s Modulus of the fibers 
are shown in Figure 3.8 (c). Additionally, yield strain (%), yield stress (MPa), Young׳s modulus 
(MPa), strain at break (%), and stress at break (MPa) are listed in Table 3.1 for different PCL 
microfibers.  
 
  
Figure 3.8 (a) Tensile stress–strain behavior, (b) enlarged view of the elastic region of stress–
strain curve, and (c) Young׳s modulus of PCL microfibers fabricated with different flow rate ratios 
with the PCL concentration of 5% in TFE. 
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Table 3.1 Mechanical properties of PCL fibers made by different sheath-to-core flow rate ratios. 
Flow rate 
ratio 
Yield strain 
(%) 
Yield stress 
(MPa) 
Young׳s 
modulus 
(MPa) 
Strain at 
break (%) 
Stress at 
break 
(MPa) 
40:5 2.70±0.65 6.02±1.02 247.25±32.08 567±61.24 24.51±3.11 
20:5 3.78±0.24 15.78±1.50 420.03±38.89 1079.25±63.20 57.35±5.46 
10:5 3.92±0.33 20.05±1.15 539.70±14.50 1420.4±79.47 77.07±5.64 
 
The results show that the decrease of the flow rate ratio from 40:5 to 10:5, significantly 
improves the tensile stress at break, tensile strain at break, and the Young׳s modulus from 
24.51 MPa to 77.07 MPa, 567% to 1420%, and 247.25 MPa to 539.70 MPa, respectively. The 
yield stress (MPa) and yield elongation (%) improve by a factor of 3.33 and 1.45 when the flow 
rate ratio decreases from 40:5 to 20:5.  
Although the mechanical properties of electrospun PCL fibrous scaffold widely have been 
studied, there are few reports about the mechanical properties of PCL single fibers made by 
electrospinning method. It was found that the reported values of the tensile strain at break (%) for 
electrospun fibers are significantly lower than our results [46-49]. This could be due to the 
microstructure organization of the fibers as the shear stress plays a pivotal role in aligning the 
polymer chains in the direction of the flow and consequently creating highly structured fibers. 
However, the values of stress at break and Young׳s modulus obtained in this study are comparable 
with the ones reported for the electrospun PCL fibers. Also based on the SEM images of microfiber 
cross sections shown in Figure 3.4, decreasing the flow rate ratio leads to an increase in the size 
and aspect ratio of the fiber cross section such that the fiber cross section tends to have a ribbon 
shape. Consequently, this improvement in mechanical properties of microfibers can be due to the 
ribbon shape of the microfiber cross-section. 
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3.6 Conclusions 
PCL microfibers with improved mechanical properties were fabricated using the 
microfluidic fiber fabrication. Employing microfluidic fiber fabrication approach, we created 
microfibers with the maximum strain of 1420%. We showed through SEM that the morphology 
and size of the fibers could be controlled by varying the PCL percentage in the core solution and 
the flow rate ratio of sheath to core fluids. While the smoothness of the fiber was improved by 
increasing the PCL concentration in the core solution from 2% to 8%, the flow rate ratio did not 
have a substantial influence on the roughness of the fiber. The aspect ratio of the fiber increases 
by diminishing the flow rate ratio because when the sheath flow rate decreases, the core fluid 
expands in the channel, which increases the width of the fiber. Numerical simulations were 
consistent with the experimental results. This development in size and cross section of the fiber 
enhanced the mechanical properties of the microfiber. These are the most improved properties 
compared to those of the previous reports about PCL fibers created using other fabrication 
methods. This improvement reveals unique capability of microfluidic platform to create fibers with 
a wide range of mechanical properties simply by changing the fabrication parameters such as flow 
rate ratio and viscosity.  
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CHAPTER 4 
POLYCAPROLACTONE MICROFIBROUS SCAFFOLDS TO NAVIGATE NEURAL STEM 
CELLS 1 
 
ABSTRACT 
Fibrous scaffolds have shown promise in tissue engineering due to their ability to 
improve cell alignment and migration. In this paper, poly(ε-caprolactone) (PCL) fibers are 
fabricated in different sizes using a microfluidic platform. By using this approach, we 
demonstrated considerable flexibility in ability to control the size of the fibers. It was shown that 
the average diameter of the fibers was obtained in the range of 2.6–36.5 μm by selecting the PCL 
solution flow rate from 1 to 5 μL min–1 and the sheath flow rate from 20 to 400 μL min–1 in the 
microfluidic channel. The microfibers were used to create 3D microenvironments in order to 
investigate growth and differentiation of adult hippocampal stem/progenitor cells (AHPCs) in 
                                                            
1 F. Sharifi, B. Patel, A. Dzuilko, R. Montazami, D.S. Sakaguchi, and N. Hashemi, "Polycaprolactone Microfibrous 
Scaffolds to Navigate Neural Stem Cells", Biomacromolecules, 17, 3287-3297 (2016). 
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vitro. The results indicated that the 3D topography of the PCL substrates, along with chemical 
(extracellular matrix) guidance cues supported the adhesion, survival, and differentiation of the 
AHPCs. Additionally, it was found that the cell deviation angle for 44–66% of cells on different 
types of fibers was less than 10°. This reveals the functionality of PCL fibrous scaffolds for cell 
alignment important in applications such as reconnecting serious nerve injuries and guiding the 
direction of axon growth as well as regenerating blood vessels, tendons, and muscle tissue. 
Moreover, the PCL fibers with different sizes and shapes (straight and wavy), were used to 
quantitatively analyze the cell adhesion, proliferation, and differentiation. Our first replicate 
showed that 5 μm had the most cell adhesion, 5 μm, straight 20 μm, and wavy 35 μm provided 
significantly better condition for the glial differentiation compared to control. More cell 
proliferation was observed on the wavy 35 μm fibers when compared to straight 35 μm fibers, 
showing that fiber morphology may have an effect on cell proliferation. However, this study 
goals to perform two more replicates in order to have more reliable results. 
 
4.1 Introduction 
Tissue engineering is an interdisciplinary area that combines engineering and biology in 
order to improve or replace biological functions [1, 2]. This area can be equipped by 
microfabrication methods, which are powerful tools with extremely high potential to handle 
some of the obstacles in tissue engineering [3]. In most applications, scaffolds are made of 
biomaterials and applied in order to provide a suitable 3D environment with intentions toward 
controlling cell behavior, such as adhesion, proliferation, differentiation, migration, alignment, 
and in providing efficient nutrient transport as well as sufficient mechanical properties [4, 5]. 
However, there are some challenges in tissue engineering; the biomaterial must be compatible 
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with the cells in question in order to sustain reasonably normal behaviors. As such, it is essential 
to gain a better understanding of the microenvironmental conditions required to regulate the cells 
fate. Additionally, tissue engineering suffers from a lack of biomaterials with desirable 
biological, chemical, and mechanical properties [4]. To meet this need, enormous efforts have 
been made to discover new biomaterials and to study the biocompatibility and biodegradability 
of different materials [6, 7].  
A prominent area of tissue engineering is related to regenerative medicine and 
neurorepair. The discovery of effective therapeutic interventions targeted toward 
neurodegenerative conditions and nerve injuries has proven challenging. Scientists and engineers 
have been drawn into the field of neural tissue engineering due to its importance for development 
of novel therapeutic strategies. For example, peripheral nerve regeneration is a complicated 
phenomenon which is often successful as long as the injuries are small. With more severe nerve 
injuries such as a nerve gap, however, interposition of a nerve graft or nerve regeneration conduit 
is usually required. Complexity in spinal cord injury is more serious since, for the most part, 
regeneration is prohibited. Fortunately, neural tissue engineering provides extraordinary promise 
to combat this central nervous system (CNS) injury [8]. For example, Hurtado et al. 
demonstrated axonal regeneration within a spinal cord injury using aligned poly-L-lactic acid 
microfibers [9]. Microfibers may provide a supportive environment for a recovering nervous 
system due to the combination of physical and biological cues. 
Microfibers have been fabricated for neural tissue engineering using different approaches 
such as microfluidics, electrospinning, and wet spinning [10]. Agarwal et al. reported some of 
the studies in electrospinning fiber fabrication technique for biomedical applications such as 
tissue engineering and drug delivery [11, 12]. Polycaprolactone (PCL) is one of the 
64 
 
biocompatible and biodegradable polymers applied for the fibers fabricated in this technique [12-
16]. Schnell et al. showed that using electrospun PCL and collagen/PCL fibers can significantly 
improve the attachment, migration, and neurite orientation of Schwann cells [12]. In addition to 
PCL, other biocompatible polymers have been used in nerve tissue engineering such as gelatin 
and polylactic acid (PLA) [17, 18]. However, accurately aligning the fibers in electrospinning 
method is difficult [13, 17, 19]. This method is not functional for cell encapsulating purposes due 
to the fact that the size of the fibers are mostly limited to nanoscales. Furthermore, high voltages 
(5–50 kV) need to be applied for pulling the charged solution, which might damage sensitive 
biological materials. Wet spinning method has been employed in nerve tissue engineering as 
well. Siriwardane et al. fabricated collagen fibers and treated them by cross-linkers 
glutaraldehyde and genipin in order to improve the mechanical properties and decrease swelling 
[20]. In wetspinning, the sample is exposed to chemicals and osmotic gradients for a relatively 
long time, which can have detrimental effects on the cells [21, 22]. Additionally, the cross 
section of the fibers made by electrospinning and wetspinning are mostly round due to the 
surface tension in the two-phase systems of liquid/air and immiscible liquid/liquid, respectively 
[23].  
Microfluidics is an interdisciplinary field that has received much attention, mostly 
because of its wide applications from energy systems to biomedical areas [24-29]. Microfluidic 
fiber fabrication, which is the newest approach, retains most advantages of other fiber fabrication 
approaches and minimizes some of their shortcomings. One of the important features of using 
microfluidic fiber fabrication is the compatibility with cells, proteins, drugs, and peptides as well 
as versatility, cost-effectiveness, and simplicity [5, 28, 30, 31]. In this method, there is no need to 
apply high temperature, high pressure, and high voltages [5, 23, 25, 30, 32, 33]. This approach 
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makes it feasible to fabricate fibers with different shapes of solid [23, 34-38], tubular [39, 40], 
hybrid [41], and flat [42-44] dimensions for divergent applications such as cell encapsulation, 
alignment, and immobilization.  
In terms of material, there are both synthetic and natural biodegradable and 
biocompatible polymers. We used PCL, a synthetic polymer, in this study. Synthetic polymers 
have some advantages over the natural materials. For example, the polymer composition can be 
accurately controlled such that a wide range of properties is obtainable for the synthetic 
polymers. In addition, they are more uniform with sufficient source of raw materials [45, 46]. 
Comparing with other synthetic polymers, such as PLGA, PCL has slower degradation rate, 
which makes it less acidic during degradation and desirable for long-term implantable devices. 
Although some studies focused on using the PCL electrospun fibrous scaffolds in nerve tissue 
engineering, there is no report on employing hydrodynamic focusing (microfluidic approach) and 
solvent extraction to fabricate biocompatible PCL fibers in nerve regeneration tissue engineering 
[47, 48]. 
In this paper, we show that microfluidic fiber fabrication may be used as a scalable and 
widely accessible alternative technique to fabricate PCL fibrous scaffolds with tuned 
characteristics to enhance the growth and differentiation of neural stem cells as well as neurite 
orientation. We cultured green fluorescent protein-expressing (GFP) adult hippocampal 
stem/progenitor cells (AHPCs) on PCL microfibers and investigated their ability to adhere, 
survive, proliferate and differentiate. AHPCs were used because of their ability to differentiate 
into the fundamental cells of the CNS. In order to study CNS regeneration therapies, it is 
important to consider the population of cells needed for repair of a damaged nervous system. The 
AHPCs were maintained in medium supplemented with bFGF and upon growth factor 
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withdrawal, these multipotent AHPCs differentiated into neurons and glial cells [49, 50]. 
Neurons are able to transmit information and are the key cells of the nervous system, whereas 
glial cells serve as the support cells of the CNS. The microfluidic microfabrication platform was 
able to create a biocompatible scaffold out of fibers to provide a desirable growth environment 
for the neural stem cells. We showed that the cells attach to and align themselves on the 
microfiber substrates. In this study, cell death was minimal, and cell proliferation was affected 
by changing the features of the fibrous scaffold. Ideally, as the scaffold is degraded a more 
natural microenvironment is created by the cells and the production of their extracellular matrix 
(ECM), thus resulting in a bioengineered 3D network that mimics the native tissue. 
 
4.2 Experimental Section 
4.2.1 Materials 
Poly(ε-caprolactone) (PCL) (Mn = 80 000), polyethylene glycol (PEG) (Mn = 20 000), and 
ethanol were purchased from Sigma-Aldrich (St. Louis, MO). 2,2,2-Trifluoroethanol (TFE), 
which is the solvent for PCL, was obtained from Oakwood Chemical (West Columbia, SC). 
 
4.2.2 Microfluidic channel 
A SU8 photoresist-patterned silicon wafer was applied as a mold and the channel was 
made using soft lithography. We used two silicon wafers in order to create the pattern of the 
microchannel and the chevron grooves extended from two sides of the channel. The dimensions 
of the microchannel are 130 μm × 390 μm (height × width). The microchannel has four diagonal 
grooves with dimensions of 130 μm × 100 μm (height × width) and are spaced 200 μm apart. 
Polydimethylsiloxane (PDMS), which is a biocompatible and transparent elastomer, was made 
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from the mixture of Sylgard 184 elastomer base and cross-linker agents in a 10:1 ratio. Then, the 
mixture was poured onto the mold, and cured with the temperature of 85 °C for 25 min. After 
that, the PDMS layer on the silicon wafers were peeled off and the layers were bonded together 
using plasma treatment.  
 
4.2.3 Microfluidic fiber fabrication 
The 5 wt % PCL solution (core fluid) was obtained by mixing 1 g of PCL in 20 mL TFE 
at room temperature. The sheath solution was prepared by adding 1 g of PEG in 20 mL mixture 
of ethanol and deionized (DI) water with a volume ratio of 1:1 to prepare 5 wt % PEG solution. 
These two solutions were introduced into the microchannel via a double syringe pump (Cole-
Parmer, Veron Hillss, IL) with different flow rate ranges of 2–5 μL min–1 and 10–120 μL min–
1 for the core and sheath solution, respectively. Using this method, the fibers remain aligned after 
fabrication. The microchannel was vertically positioned into a water bath, and the resulting fibers 
were gathered around a paper frame in an aligned manner. 
 
4.2.4 Cell culture 
Adult hippocampal progenitor cells (AHPCs) were originally isolated from adult Fischer 
344 rats and infected with a retrovirus to express green fluorescence protein (GFP) as described 
previously and were a generous gift from F. H. Gage (Salk Institute for Biological Sciences, La 
Jolla, CA) [51]. Cells were grown in flasks coated with poly-L-ornithine (10 μg mL–1; Sigma-
Aldrich) and purified mouse laminin (5 μg mL–1; R&D Systems) in Earle’s balanced salt solution 
(EBSS). Maintenance media (MM) included Dulbecco’s modified Eagle’s medium/Ham’s F-12 
(DMEM/F-12, 1:1; Omega Scientific), supplemented with 2.5 mM L-glutamine, N2 supplement 
68 
 
(Gibco BRL), and 20 ng mL–1 basic fibroblast growth factor (human recombinant bFGF; 
Promega Corporation). The AHPCs were detached from flasks using 0.05% trypsin–EDTA 
(Gibco BRL) and harvested by centrifugation at 800 rpm for 5 min. A hemocytometer was used 
to perform a Trypan Blue viable cell count, and AHPCs were plated at a density of 10 000 
cells/cm2 on PCL-microfiber substrates (see below). Cells were maintained at 37 °C in a 5% 
CO2/95% humidified air atmosphere. For cell differentiation, AHPCs were cultured in growth 
medium lacking bFGF (referred to as differentiation medium, DM) for 7 days. Half of the media 
was changed every other day.  
 
4.2.5 Substrate preparation 
Glass coverslips (12 mm, Fisher Scientific) were cleaned using RBS 35 (Thermo 
Scientific) detergent diluted (1:50) in deionized water and boiled for 15 min. Coverslips were 
then rinsed in DI water, air-dried and ultraviolet light was used for sterilization. The microfibers 
were then attached to the coverslips using medical adhesive. Small droplets of medical adhesive 
were placed at opposite sides of the coverglass and a parallel array of microfibers placed across 
the coverglass and attached to the medical adhesive droplets. Small chip of coverglass were then 
used to secure the microfibers to the coverglass. The microfibers were fixed at opposite ends and 
loose across the middle of the coverglass. The coverglass and PCL-microfiber substrates were 
sterilized by incubation in 70% ethanol for 20 min and rinsed with Earle’s balanced salt solution 
(EBSS; Invitrogen). After 10 min of air-drying, the microfiber substrates were incubated at 4 °C 
overnight with Entactin-Collagen IV-Laminin (ECL; Millipore) at 10 μg mL–1 in DMEM/F-12 to 
facilitate cell attachment. The next day, the ECL was removed, samples were rinsed with EBSS, 
and cells plated. 
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4.2.6 Immunocytochemistry 
After 7 days of culturing in DM, the cells were rinsed with 0.1 M phosphate (P04) buffer 
and immediately fixed with 4% paraformaldehyde (PFA) in 0.1 M P04 buffer for 20 min at room 
temperature. PFA was removed and rinsed with phosphate buffer saline (PBS; Invitrogen) and 
incubated in blocker solution (PBS supplemented with 5% normal donkey serum (Jackson 
ImmunoResearch), 5% normal goat serum (Jackson ImmunoResearch), 0.4% bovine albumin 
serum (Sigma), and 0.2% Triton X-100 (Fisher Scientific)) at room temperature for 1 h. Primary 
antibodies were diluted in blocker solution and samples incubated at 4 °C overnight. On the 
following day, antibodies were removed and samples were rinsed with PBS. Secondary 
antibodies, donkey anti-rabbit Cy3 and donkey anti-mouse Cy3 (Jackson ImmunoResearch), 
were diluted in blocking solution at a dilution of 1:500 along with the nuclear stain, DAPI (1:50, 
Invitrogen). Samples were incubated in secondary antibody/DAPI solution for 90 min at room 
temperature. Samples were then mounted on microscope slides using DAPI Fluoromount-G 
(Southern Biotech) mounting media and stored at 4 °C until imaging. 
 
4.2.7 Propidium Iodide staining 
Propidium iodide (PI) was used to measure cell death/survival at 7 days in vitro. 
Propidium iodide stain solution was prepared at a concentration of 1.5 μM in culture medium. 
Half of the samples served as the positive, reagent control for the PI stain and subjected to 70% 
ethanol for 5 min to induce cell death. The ethanol and MM were removed from all samples and 
the culture media containing PI was added for 20 min at 37 °C in a 5% CO2 incubator. The 
samples were then rinsed with 0.1 M P04 buffer, fixed with 4% PFA, and rinsed again with PBS. 
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Samples were then incubated with DAPI (1:50) diluted in blocker solution for 1 h at room 
temperature. Following PBS rinses, samples were mounted on microscope slides using DAPI 
Fluoromount-G mounting media and stored at 4 °C until imaging. 
 
4.2.8 Imaging and measuring the alignment angles 
Fluorescent images were conducted using a fluorescence microscope (Nikon Microphot 
FXA, Nikon, Inc.), equipped with a Retiga 2000R digital camera controlled by QCapture 
software (QImaging). Images were pseudocolored using Adobe Photoshop CC. Scanning 
electron microscopy (SEM; JCM-6000 NeoScope Benchtop scanning electron microscope) was 
applied to study the size, morphology, and deviation angle of the fibers and cells. In order to 
acquire high quality SEM images, the substrates were made conductive using gold sputter-
coating. The coating thickness of the samples was around 50 nm. The cell and fiber deviation 
angles were measured using the SEM images and ImageJ, which is an imaging analysis software. 
For the fiber size and deviation angle, around 30 fibers were studied, whereas the positions of 
around 100 cells were evaluated relative to the fiber direction in each type of fiber. 
 
4.3 Results and Discussions 
Two fluids, i.e., the core and sheath fluids, are introduced into the microchannel and 
diffusion occurs only at the core/sheath fluid interface due to the laminar flow regime. In order to 
have a continuous fiber fabrication process, a core/sheath flow profile is required [5].  
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Figure 4.1 (a) Schematic of the microfluidic fiber fabrication. (b) Streamline and velocity (m s–
1) of the fluids along the channel. (c) Illustration of concentration profile (mol m–3): the dark 
and bright colors represent the sheath and core fluids, respectively. (d) Phase inversion process: 
the TFE molecules are replaced with the molecules of the sheath fluid, which results in PCL 
solidification. (e) Cell culture procedure: (I) Sterilization of microfibers on coverslips using 70% 
ethanol for 20 min; (II) diluted ECM substrate (ECL) in DMEM/F-12 to a final concentration of 
10 μg mL–1; (III) culture AHPCs in T-75 flask until 80% confluent; (IV) apply trypsin to cells for 
collection; and (V) culture cells on ECL-coated microfibers in differentiation media for 7 days. 
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Figure 4.1 (a) provides a schematic picture of the microfluidic fiber fabrication. The 
sheath fluid focuses the core fluid laterally after the two fluids are introduced at the upstream of 
the channel and changes the shape of the core fluid to a thin vertical strip. Chevron grooves in 
the downstream of the channel decrease the hydrodynamic resistance perpendicular to the flow 
direction. The sheath flow rate is higher than the core flow rate in order to provide the force 
needed to keep the core fluid at the center of the microchannel. Because the hydrodynamic 
resistance is inversely proportional to flow rate, the sheath fluid fills the grooves, wraps around 
the core fluid, and pushes it to the center of the channel [52-54]. The streamline and velocity 
distribution of the fluids along the channel are provided in Figure 4.1 (b). Figure 4.1 (c) 
demonstrates the concentration profile through the channel. The dark and bright colors show the 
sheath and core fluids, respectively. These figures clearly illustrate the role of the sheath fluid 
and chevron grooves to exert the lateral and vertical hydrodynamic focusing forces on the core 
fluid. The lateral and vertical hydrodynamic focusing forces, which are originated from the shear 
force between the core and sheath fluids, play a pivotal role to keep the core fluid at the center, 
align the polymer chain, and change the shape of the microfibers. 
The hydrodynamic force depends on the viscosity and relative velocity of the core and 
sheath fluids. By adding polyethylene glycol (PEG) to the sheath fluid, the viscosity of core and 
sheath solutions match and there is no need to use high relative velocities to focus the core fluid 
when fabricating the fibers. Additionally, there is a possibility of flow instability in the channel 
at high relative velocities that results in changing the flow regime to transient from laminar. 
Phase inversion (solvent extraction) strategy was used to solidify PCL and fabricate microfibers. 
In this process, 2,2,2-trifluoroethanol (TFE) in the core fluid is replaced by the ethanol and water 
in the sheath fluid at the interface between the sheath and core solution (Figure 4.1 (d)). This 
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exchange results in PCL solidification because the sheath fluid is miscible to TFE, but not 
solvent to PCL. Figure 4.1 (e) describes the sterilization and cell culture protocol for AHPCs. 
Following the plating of AHPCs, cells are incubated for 7 days in differentiation media, and 
subsequently fixed and immunolabeled for further analysis. 
Figure 4.2 shows the SEM images of the fibers fabricated using the flow rate ranges of 
1–5 μL min–1 and 20–400 μL min–1 corresponding to the core and sheath fluids, respectively. The 
concentration of the PCL in TFE and PEG in the water/ethanol were kept at a constant value of 
5%. In the phase inversion solidification process, used to solidify the PCL fibers, the molecules 
of TFE are replaced by the molecules of the sheath fluid. Due to this diffusion at the fluid/fluid 
interface, the surface of the PCL fibers are not smooth, which could provide a better environment 
for the cells to adhere to the surface of the fibers. Additionally, this figure shows consistency 
with the theory of hydrodynamic focusing meaning that when the flow rate ratio between the 
core and sheath fluids decreases, the shear force at the interface exerted from the sheath fluid to 
the core fluid weakens. Therefore, the core fluid extends in the channel and the size of the 
resulting fiber increases.  
This figure also demonstrates that once the flow rate ratio exceeds 50, the fibers will not 
be smooth anymore. This condition continues until the wavy fibers connect with each other and 
create a chain, that could be considered as a self-assembly structure (Figure 4.2 (e)). This was 
expected because when the flow rate ratio between the fluids increases, the sharp velocity 
gradient at the fluid/fluid interface intensifies the shear force, which decreases the flow stability 
and the regime starts to lie in the transition region [25].  
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Figure 4.2 SEM images of the microfluidic spun PCL microfibers at different sheath-to-core 
flow rates of (a) 20:5, (b) 60:5, (c) 200:4, (d) 300:2, and (e) 400:1. The concentrations of the 
PCL and PEG are 5% in TFE and water/ethanol, respectively. 
(a1) (a2) 
(b1) (b2) 
(c1) (c2) 
(d1) (d2) 
(e1) (e2) 
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The average size and production rate of the fibers (mean ± standard error) are shown in 
Figure 4.3 (a) and (b), respectively. The results show that the diameters of the fibers lie in the 
range of 2.6–36.5 μm, which can be obtained by changing the sheath-to-core flow rate of 400:1–
20:5, respectively. This figure demonstrates the capability of the microfluidic fiber fabrication in 
tuning the size of the fibers by simply changing the flow rate ratio between the sheath and core 
fluids. As expected, the production rate of the fiber directly depends on the sheath and core flow 
rates. The maximum production rate was 37 mm s–1 for the sheath-to-core flow rates of 400:1, 
and it decreases to 6.5 mm s–1 when the sheath-to-core flow rate of 60:5 is used. However, it 
does not mean that the range of the production rate in microfluidic approach is limited. We can 
increase the production rate by increasing the sheath and core flow rates. However, in this study, 
we mostly focused on studying the alignment of the AHPCs on fibers with different sizes. The 
small error bars reveal the uniformity of the size and production rate of the fibers made by this 
method. Figure 4.3 (c) illustrates the alignment of different types of fibers by presenting the 
percentage of fiber deviation angle, i.e., the angle between each one of the fibers and a reference. 
This figure shows that the percentage of the fibers with fiber deviation angle larger than 10° are 
5.55%, 0%, 0%, 2.38%, and 6.1% for the sheath-to-core flow rates of 20:5, 60:5, 200:4, 300:2, 
and 400:1, respectively. This shows one of the advantages of microfluidic approach over 
common fiber fabrication methods, which is the feasibility of this method to simply fabricate the 
aligned fibers. 
Ki-67 immunolabeling was used to evaluate whether the PCL microfibers would support 
proliferation of the AHPCs. Expression of the Ki-67 antigen occurs during the cell cycle (not 
detected in cells in the resting phase) and therefore is commonly used as a cellular marker for 
cell proliferation. Ki-67 immunolabeled cells were present on all microfibers examined.  
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Figure 4.3 Characteristics of the PCL microfibers: (a) size, (b) production rate, and (c) alignment 
of the fibers fabricated using different sheath-to-core flow rate ratios. 
 
Figure 4.4 (A-C) illustrates an example of Ki-67 immunolabeled cells growing on 
microfluidic spun PCL microfibers at a sheath-to-core flow rate of 60:5. Propidium iodide staining 
was used to evaluate survival of AHPCs growing on the microfibers (Figure 4.4 (D-I)). Propidium 
iodide is a fluorescent nuclear and chromosome counterstain that is membrane impermeant and 
commonly used to identify dead cells in a population. 
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Figure 4.4 Proliferation and survival of AHPCs cultured on PCL microfibers. Fluorescence 
images of AHPCs immunolabeled for Ki-67, cell proliferation marker (A−C) or propidium 
iodide (PI) staining. Middle column of images illustrate GFP-expressing AHPCs (B, E, and H). 
As a control for the PI staining reagents, samples were subjected to ethanol (EtOH) treatment 
that causes most cells to die resulting in extensive PI staining (G, H, and I). Merged images (C, 
F, and I) of antibody labeling or PI-staining (red) with GFP-expression (green) and DAPI nuclei 
counterstaining (blue). Scale bar = 100 μm. 
Figure 4.4 (D-F) shows that very few PI-positive cells were detected in the microfiber 
cultures. In contrast, as a positive control for the PI reagents, some samples were subjected to 
70% ethanol, a condition that kills most cells, resulting in the majority of cells PI-labeled 
(Figure 4.4 (G-I)). It is notable that the cells remained attached following the 70% ethanol 
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treatment. This is likely due in part to the immediate fixation in paraformaldehyde. Furthermore, 
the ECL substrate absorption onto the PCL microfibers facilitates cell attachment. Taken 
together, the Ki-67 immunolabeling and Propidium Iodide staining results indicate that the 
different PCL microfibers produced by the different sheath-to-core flow rates all supported 
adhesion and cell proliferation, and did not dramatically affect cell viability. 
AHPCs growing on the different PCL microfibers were characterized morphologically 
and immunocytochemically using a panel of cell-type specific antibodies. The AHPCs are a 
multipotent population of adult neural stem cells and have the capacity to differentiate into 
neurons, oligodendrocytes and astrocytes [50]. The phenotypes of AHPCs growing on the 
microfibers were assessed using antibodies directed against nestin, an intermediate filament 
protein present in neural stem/progenitor cells; class III β-tubulin (TuJ1), a protein characteristic 
of early neurons; microtubule-associated protein 2ab (MAP2ab), characteristic of maturing 
neurons; and the glial markers, receptor interacting protein (RIP) and glial fibrillary acidic 
protein (GFAP), for oligodendrocytes and astrocytes, respectively. AHPCs were identified in 
culture based on green fluorescent protein GFP-expression and counterstaining with DAPI 
allowed visualization of the cell nuclei. Many of the AHPCs were immunolabeled with the 
nestin, TuJ1 and MAP2ab antibodies (Figure 4.5), fewer cells were immunoreactive for the glial 
markers RIP and GFAP.  
Figure 4.5 (A-I) illustrates examples of AHPCs growing on microfluidic spun PCL 
microfibers at a sheath-to-core flow rate of 300:2 that were immunolabeled with the nestin 
(Figure 4.5 (A-C)), TuJ1 (Figure 4.5 (D-F)) or MAP2ab (Figure 4.5 (G-I)) antibodies.  
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Figure 4.5 Attachment and differentiation of AHPCs cultured on PCL microfibers. Fluorescence 
images of AHPCs immunolabeled for nestin (A–C), TuJ1 (D–F), and MAP2ab (G–I). Middle 
column of images illustrate GFP-expressing AHPCs (B, E, and H). Merged images (C, F, and I) 
of antibody labeling (Cy3, red) with GFP-expression (green) and DAPI nuclei counterstaining 
(blue). Asterisks indicate the location of the higher magnification inset images in (A), (D), and 
(G). Attachment of cells is seen through immunolabeling of processes around microfibers. Scale 
bar = 100 μm (200 μm for insets). 
 
Nestin, a marker for multipotent neural stem cells, has important functions in the survival 
and self-renewal of NSCs. AHPCs immunolabeled for nestin indicates that many of the cells 
growing on the PCL microfibers retained their progenitor-like status. Under differentiation 
conditions (initiated by growth factor withdrawal) AHPCs begin differentiating and many cells 
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were immunolabeled with the neuronal markers TuJ1 and MAP2ab. Immunolabeled cells 
displayed neuronal morphologies, often exhibiting longer neurites of various lengths on the 
microfiber surface. Though all three antibody markers (nestin, TuJ1, and MAP2ab) label 
different cytoskeletal elements, all are expressed within the cytoskeleton of the neurite processes 
as was clearly evident in the fluorescent images (Figure 4.5). It was noted that some of the 
AHPCs undergo a decrease in expression of GFP during the course of cell culture, indicating a 
down regulation of the GFP transgene during the course of establishment of stable cell 
populations that allow long-term culture. However, these low GFP expressing AHPCs continued 
to survive, proliferate, and differentiate in a normal fashion.  
The SEM images of AHPCs on the PCL microfibers are shown in Figure 4.6. This figure 
illustrates that most of the cells can be aligned to the longitudinal direction of the fibers with 
different sizes. This reveals the role of the fibers as scaffolds to be applied for supporting the 
proliferation and differentiation of AHPCs. However, the fibers with larger sizes can physically 
support more cells on their surfaces compared to smaller ones. The SEM images with higher 
magnifications are provided in Figure 4.7 (a-e).  
In terms of the size of the aligned PCL fibers, this figure shows that while the 
predominant alignment of the cells is in the axial direction of the fibers, the cells on fibers with 
the average size of 4–7 μm on occasion bridged from one fiber to another one (Figure 4.7 (d)). 
The likely reason for such behavior is that the distance between the thinner fibers is shorter and 
that bundles of fibers have been created. As a result, the cell can bridge between two fibers. 
However, Figure 4.7 (e) demonstrates that this behavior is not observed for the thinnest fiber. 
That is because the fibers are wavy (Figure 4.2 (e)) due to the large velocity difference between 
the core and sheath fluids and resulting instability. 
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Figure 4.6 SEM images of the AHPCs growing on PCL microfibrous scaffolds fabricated by 
using different sheath-to-core flow rates of (a) 20:5, (b) 60:5, (c) 200:4, and (d) 300:2. PCL and 
PEG concentrations are 5% in TFE and water/ethanol, respectively. 
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Figure 4.7 (a–e) SEM images of the AHPCs cultured on the PCL microfibers. (f) Illustration of 
cell deviation angle. (g) Quantification of the neurite orientation on the fibers. 
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It is possible that when placed in cell culture, the fibers become braided such that it is 
more difficult to separate the fibers from each other. When the fibers with the flow rate ratio of 
400:1 are braided, a uniform bundle is created which allows more cells to attach on the surface 
due to increase surface area. Additionally, the empty space between the fibers may mimic a 3D 
microenvironment for the cells in order to allow nutrients to be exchanged to increase survival of 
cells. It can be observed that although this type of fiber is wavy and develop in different 
directions, the ultimate direction of all of the fibers are in the same direction. However, it was 
reported that the mechanical properties of the PCL fibers decrease with increasing flow rate ratio 
[25]. Therefore, if high mechanical properties are required, larger fibers are better choices for the 
PCL fibrous scaffolds that provide enough strength as well as a desirable microenvironment for 
aligning the cells. The neurite orientation on the fibers was analyzed quantitatively based on 
SEM images by measuring the cell deviation angle, which is the angle between the main axis of 
the cells and the fibers (Figure 4.7 (f)). The results of measuring the cell deviation angle are 
shown in Figure 4.7 (g). This figure demonstrates that the cell deviation angle is mostly less than 
10° for fibers with different sizes, which reflects that the PCL microfibers were able to align the 
AHPCs efficiently along their axial directions. The percentage of the cells with deviation angle 
lower than 10° is 61%, 53%, 63%, 44%, and 66% for the fibers fabricated using the sheath-to-
core flow rate ratio of 20:5, 60:5, 200:4, 300:2, and 400:1, respectively. The percentage of the 
cells with deviation angle larger than 10° decreases significantly. However, number of the cells 
with the cell deviation angle in the range of 70–90° increases to the maximum values of 29% and 
35% on the fibers made by the sheath-to-core flow rate of 200:4 and 300:2, respectively due to 
cells bridging within the bundles of microfibers. 
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We continued this work to study the cell adhesion, survival, proliferation, and 
differentiation quantitatively. For this study, we fabricated fibers with different sizes (5 μm, 20 
μm, and 35 μm) and shapes (straight and wavy). Table 4.1 shows the PCL concentration and 
flow rate ratio between the core and sheath fluids, used to fabricate fibers with different 
characteristics.  
Table 4.1 PCL fibers with different characteristics. 
PCL concentration 
(%) 
Sheath-to core flow 
rate ratio (μL/min)
Diameter (μm) Shape 
5 200:2 5 Chain shape 
2 150:10 20 Straight 
5 150:5 20 Wavy 
5 50:10 35 Straight 
5 90:5 35 Wavy 
 
 
Figure 4.8 AHPC’s growing on PCL microfiber. (A,C) cultures were stained for TuJ1 (red), 
GFP (green) and DAPI (cell nuclei, blue) all merged with DIC. (B,D) cultures were stained for 
MAP2ab (red), GFP (green) and DAPI (cell nuclei, blue) all merged with DIC. Top row: 20 μm 
scale bar. Bottom row: 10 μm scale bar.  
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Proliferating cells were immunolabeled with Ki67 antibody, neural progenitor/stem cells 
detected with Nestin antibody, neuronal cell differentiation characterized by TuJ1 and MAP2ab 
antibodies, and glial cell differentiation characterized by GFAP and RIP antibodies. Figure 4.8 
and 4.9 are microscopic images that indicate in more detail that the PCL microfibers support cell 
adhesion, survival, proliferation and differentiation of the AHPCs.  
 
 
Figure 4.9 AHPC’s growing on PCL microfiber. (A,C) cultures were stained for GFAP (red), 
GFP (green) and DAPI (cell nuclei, blue) all merged with DIC. (B,D) cultures were stained for 
RIP (red), GFP (green) and DAPI (cell nuclei, blue) all merged with DIC. Top row: 20 μm scale 
bar. Bottom row: 10 μm scale bar.  
 
Figure 4.10-4-12, show the quantitative results of cell adhesion, proliferation, and 
differentiation, respectively on PCL microfluidic-spun fibers for one replicate. It should be 
mentioned that this study aims to determine the most biocompatible PCL fiber by performing 
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three individual replicates. For the quantification, five different sites were imaged and analyzed. 
The results show that the 5 μm has the most cell adhesion. Wavy 35 μm shows more 
proliferation when compared to straight 35 μm fibers indicating fiber morphology may have an 
effect on cell proliferation. For glial differentiation, 5 μm, straight 20 μm, and wavy 35 μm are 
statistically significant compared to control. 
 
 
Figure 4.10 Number of cells per mm2 adhered to microfiber samples. 
 
 
Figure 4.11 Percentage of cells stained positive for Ki67 on PCL microfibers. 
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Figure 4.12 Percentage of cells stained positive for neuronal marker (TuJ1) and glial marker 
(GFAP) on PCL fibers.  
 
4.4 Conclusions 
Aligned PCL microfibers with different features were fabricated in this study using 
microfluidic fiber fabrication. The mean diameter of the fabricated fibers ranged from 2.6 to 36.5 
μm by selecting the sheath-to-core flow rate ratio from 400:1 to 20:5. The mean deviation angles 
(±standard error) were found 3.95 ± 0.70, 4.64 ± 0.51, 3.84 ± 0.50, 4.39 ± 0.54, and 4.88 ± 0.62 
for the sheath-to-core flow rates of 20:5, 60:5, 200:4, 300:2, and 400:1, respectively. The fibers 
were coated with a complex extracellular matrix substrate via physical absorption to facilitate 
cell attachment and for guiding the direction of AHPC growth in vitro. The results showed that 
the PCL fiber can be used as a fibrous scaffold which is not cytotoxic to the AHPCs, and 
supports cell adhesion, differentiation, and proliferation. Additionally, it was shown that the 
clusters of these adult neural stem cells can be aligned using the PCL microfibers. The 
quantitative analysis demonstrated that the cell deviation angle for most of the cells guided by 
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different types of fibers was less than 10°. On average, 58% of the cells in all types of the fibers 
had a cell deviation angle less than 10°, revealing the functionality and potential of the PCL 
microfibers for guiding nerve regeneration within the central (CNS) and peripheral nervous 
system (PNS) and may facilitate repair of spinal cord injuries (SCI) and peripheral nerve injuries 
(PNI). This integration of multiple cues within a 3D context is important for gaining a better 
understanding in regulating neural stem cell differentiation and in designing scaffolds for neural 
tissue engineering. Additionally, the PCL fibers with different sizes and shapes (straight and 
wavy), were used to quantitatively analyze the cell adhesion, proliferation, and differentiation. 
Our first replicate showed that 5 μm had the most cell adhesion; the 5 μm, straight 20 μm, and 
wavy 35 μm provided significantly better condition for the glial differentiation compared to 
control. More cell proliferation was observed on the wavy 35 μm fibers when compared to 
straight 35 μm fibers, showing that fiber morphology may have an effect on cell proliferation. 
However, this study goals to do two more replicates in order to have more reliable results. 
In addition, we are currently implanting bundles of PCL microfibers into conduits, and 
the preliminary results suggest that this approach may aid in regeneration of severed nerve 
injuries. By mimicking the microenvironment of the nervous system, regeneration can be 
enhanced due to biological and chemical cues in the environment. Using conduits with PCL 
microfiber bundles can be investigated for various regeneration strategies including central 
nervous system diseases in order to repair a damaged system. In addition, the PCL fibers can be 
applied in regeneration of other tissues such as muscle, tendons, and blood vessels.  
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CHAPTER 5 
DEVELOPMENT OF PHOTO-CROSS-LINKED POLY(ETHYLENE GLYCOL) 
DIACRYLATE HYDROGEL FROM SPHERICAL MICROPARTICLES TO BOW TIE-
SHAPED MICROFIBERS VIA MICROFLUIDIC APPROACH 
 
ABSTRACT 
Poly(ethylene glycol) (PEGDA) hydrogel was photo-polymerized in a wide range of 
shapes via a microfluidic approach. In this work, we showed that with immiscible and miscible 
fluids, spherical microparticles and bow tie-shaped fibers can be fabricated using PEGDA. The 
flow rate ratio between the core and sheath fluids is found to be an important parameter in 
accurately tuning the diameter of the particles as well as cross-section and size of the fibers. 
Glucose, sucrose, collagen, gelatin, PEG, and PVA were incorporated into the PEGDA fibers to 
study the porosity of the resulting fibers. It was found that sucrose and PVA can create porosity 
on the surface of the fibers after soaking the fibers in water for 6 days at 37 °C. The tensile 
properties of the PEGDA fibers with different characteristics were tested. It was found that when 
the core flow rate increases, the resulting fibers become more stiff and brittle, which might be due 
to the increase of the cross-linking density. The mechanical properties of the PEGDA/collagen 
drop due to the low strength of the collagen, which is a natural polymer. On the other hand, the 
incorporation of glucose could improve the tensile properties of PEGDA fibers. In addition, we 
encapsulated the AHPCs into the PEGDA fibers in order to create a cell-laden fiber. Propidium 
Iodide (PI) was used for the cell viability, and the results showed that the cells could not survive. 
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We believe that another hydrogel or the same polymer with higher molecular weight needs to be 
used in order to increase the cell survival into the hydrogel network. 
 
5.1 Introduction 
Hydrogels are insoluble three-dimensional cross-linked networks made from hydrophilic 
polymer chains that swell in aqueous solutions [1, 2]. They can be used in a wide range of 
biomedical applications such as cell encapsulation [3-5], tissue engineering [6-8], wound dressing 
[9, 10], and drug delivery [11-13] due to their high biocompatibility and versatile mechanical 
properties. Additionally, the transport of oxygen, nutrients and other water-soluble metabolites is 
efficient through the hydrogel network, which diminishes buildup of acid products in the hydrogels 
and makes them good candidates to be used as scaffolds in tissue engineering [14, 15].  
There are various methods for synthesizing physical and chemical hydrogels [16]. 
Photopolymerization is a biocompatible strategy used for creating chemical hydrogels because 
they can be formed in situ, and a minimum invasive environment is created [17]. There is no need 
for high or low temperatures, which can be important when the biological micro-molecules such 
as cells, bacteria, and enzymes are incorporated into the prepolymer solution [18, 19]. In this 
process, liquid monomers or macromeres can be photopolymerized in the presence of 
photoinitiators via visible or ultraviolet (UV) light both in vivo and in vitro.  
Microfluidics is an emerging area in both science and technology since it uses small 
amounts of material and can play astounding roles in a wide range of areas such as biomedical 
areas, optics, and energy systems [20-27]. This approach can be used to fabricate polymeric 
materials with various shapes such as particles and fibers [19, 28-33]. The microfluidic 
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particle/fiber fabrication is a cost-effective, simple, and highly biocompatible platform. Change in 
environmental condition such as temperature or pressure is not needed in this method. 
Additionally, the other advantage of this approach is its versatility, which makes it feasible to 
accurately obtain different sizes, microstructures, and morphologies and tune the mechanical 
properties within a desirable range [22, 23, 34, 35]. One of the solidification strategies used in 
microfluidic particle/fiber fabrication is the aforementioned photopolymerization. The advantage 
of this approach is that the polymerization happens in a fraction of a second, which could be useful 
for the conditions in which microsctructures with accurate patterns are desirable [33].  
Poly(ethylene glycol) diacrylate (PEGDA) is used in various biomedical applications due 
to its high biocompatibility. It is one of the derivatives of PEG that contains acrylate group in its 
chain, which makes it possible to form chemical hydrogel via crosslinking reaction. PEGDA has 
been used in microfluidic particle/fiber fabrication [33, 36, 37]. In this work, we apply the 
microfluidic approach to fabricate both PEGDA spherical particles and ribbon shaped fibers using 
immiscible and miscible fluids, respectively. The bow tie shaped fibers have been fabricated using 
the microfluidic platform [34, 38-40]. However, the application of this type of fiber has been kept 
unclear. We encapsulated Adult hippocampal progenitor cells (AHPCs) into the PEGDA fibers, 
but the cells did not survive in the hydrogel network. We believe that the grooves embedded on 
the surface of the fibers can play a significant role in aligning the cells in one direction, which has 
applications in nerve tissue engineering. Additionally, we could be able to obtain a wide range of 
mechanical properties by changing the flow rate ratio between the core and sheath fluid as well as 
incorporating different contents of glucose and alginate into the core fluid.  
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5.2 Experimental Section 
5.2.1 Materials 
Poly(ethylene glycol) diacrylate (PEGDA) (Mn=575), polyethylene glycol (PEG) (Mn = 
20 000) were purchased from Sigma-Aldrich (St. Louis, MO). Irgacure 2959 was obtained from 
Hidley & Peto Company.  
 
5.2.2 Microfluidic channel 
A SU8 photoresist-patterned silicon wafer was applied as a mold and the channel was made 
using soft lithography. We used two silicon wafers in order to create the pattern of the 
microchannel and the chevron grooves extended from two sides of the channel. The dimensions 
of the microchannel are 130 μm × 390 μm (height × width). The microchannel has four diagonal 
grooves with dimensions of 130 μm × 100 μm (height × width) and are spaced 200 μm apart. 
Polydimethylsiloxane (PDMS), which is a biocompatible and transparent elastomer, was made 
from the mixture of Sylgard 184 elastomer base and cross-linker agents in a 10:1 ratio. Then, the 
mixture was poured onto the mold, and cured with the temperature of 85 °C for 25 min. After that, 
the PDMS layer on the silicon wafers were peeled off and the layers were bonded together using 
plasma treatment.  
 
5.2.3 Microfluidic particle/fiber fabrication 
The core fluid was made by mixing different concentrations of PEGDA and Irgacure 2959 
(PI) with deionized (DI) water and ethanol at room temperature. For the particle fabrication, the 
core fluid consists of 60 v% PEGDA, 40 v% ethanol, and 8 w% Irgacure 2959. We used mineral 
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oil for the sheath and bath, which is immiscible to the core fluid. On the other hand, miscible fluids 
were used for fiber fabrication. For the core fluid, we used 30 v% PEGDA, 40 v% DI water, and 
2 w% Irgacure 2959. We used 5 w% PEG solution (PEG in DI water) for the sheath fluid and DI 
water for the bath. The solutions were introduced into the microchannel via a double syringe pump 
(Cole-Parmer, Veron Hillss, IL) with different flow rates. The microchannel was vertically 
positioned into a water bath. 
 
5.2.4 Characterization and imaging  
Fluorescent images were conducted using a fluorescence microscope (Nikon Microphot 
FXA, Nikon, Inc.), equipped with a Retiga 2000R digital camera controlled by QCapture software 
(QImaging). Images were pseudocolored using Adobe Photoshop CC. Scanning electron 
microscopy (SEM; JCM-6000 NeoScope Benchtop scanning electron microscope) was applied to 
study the size and morphology of the particles and fibers. In order to acquire high quality SEM 
images, the substrates were made conductive using gold sputter-coating. The coating thickness of 
the samples was around 50 nm. The cross sections of the ribbon shaped fibers were measured using 
the SEM images and ImageJ, which is an imaging analysis software. For measuring the stress–
strain behavior of the fibers, single fiber was tested using Instron Universal Testing machine 
(Model 5569, Instron Engineering Corp., Canton, MA). For each type of the fibers, 10 samples 
were tested and the average values for each type were reported. Since the PCL fibers have high 
ductility, we used a 10 N load cell to get enough resolution, and the extension rate was set to 
20 mm/min. In this test, the samples were prepared by attaching them on a paper frame in order to 
be gripped properly by the Instron machine. After mounting the sample on the machine, we cut 
two sides of the frame to get the mechanical properties of PCL fiber. The length of the samples for 
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this test was 15 mm. The results were found using Bluehill software. A video file is provided in 
supplementary materials, that shows high ductility of the fiber during the tensile test. The stress–
strain curves were fitted with linear line for the elastic region. Second order polynomial equation 
was used for the plastic region because its coefficient of determination (R-Square) was better 
compared to the linear line for all of the data. 
 
5.2.5 Cell culture 
Adult hippocampal progenitor cells (AHPCs) were originally isolated from adult Fischer 
344 rats and infected with a retrovirus to express green fluorescence protein (GFP) as described 
previously and were a generous gift from F. H. Gage (Salk Institute for Biological Sciences, La 
Jolla, CA) [41]. Cells were grown in flasks coated with poly-L-ornithine (10 μg mL–1; Sigma-
Aldrich) and purified mouse laminin (5 μg mL–1; R&D Systems) in Earle’s balanced salt solution 
(EBSS). Maintenance media (MM) included Dulbecco’s modified Eagle’s medium/Ham’s F-12 
(DMEM/F-12, 1:1; Omega Scientific), supplemented with 2.5 mM L-glutamine, N2 supplement 
(Gibco BRL), and 20 ng mL–1 basic fibroblast growth factor (human recombinant bFGF; Promega 
Corporation). The AHPCs were detached from flasks using 0.05% trypsin–EDTA (Gibco BRL) 
and harvested by centrifugation at 800 rpm for 5 min. A hemocytometer was used to perform a 
Trypan Blue viable cell count, and AHPCs were plated at a density of 10 000 cells/cm2 on PCL-
microfiber substrates (see below). Cells were maintained at 37 °C in a 5% CO2/95% humidified 
air atmosphere. For cell differentiation, AHPCs were cultured in growth medium lacking bFGF 
(referred to as differentiation medium, DM) for 7 days. Half of the media was changed every other 
day. 
100 
 
5.3 Results and Discussions 
A schematic of the microfluidic particle/fiber fabrication is shown in Figure 5.1 (a). We 
introduced both of the core and sheath fluid into the 3 inlet microchannel. The flow regime is 
laminar and the diffusion takes place at the interface. The microchannel consists of two main 
regions: the nozzle (upstream) and four chevrons (downstream), and the polymerization occurs at 
the outlet of the channel. Figure 5.1 (b) demonstrates the photo-polymerization process of PEGDA 
hydrogel. The photoinitiator absorbs UV light and creates free radicals, which react with PEGDA 
macromers and break the carbon-carbon bond. Then, the reactive PEGDA macromers connect with 
each other and form a large molecule. For the particle fabrication, sheath fluid is wrapped around 
the core fluid at the beginning of the chevron area due to the high hydrophobicity of the mineral 
oil. On the other hands, the fiber fabrication process has some differences due to the fact that 
miscible fluids are used. In this process, the sheath fluid focuses the core fluid laterally. The 
focusing force is originated from the shear force that arises from velocity gradient at the interface 
between the core and sheath fluid. At the end of nozzle region, the core fluid changes to a vertical 
thin strip. Then, the sheath fluid fills the chevron areas and exerts vertical force on the core fluid. 
In the chevron region, the hydrodynamic resistance perpendicular to the flow direction decreases. 
The reason that the sheath fluid goes into the chevron areas is that the hydrodynamic resistance is 
inversely dependent on the flow rate. Because the sheath fluid has a higher flow rate in this 
experiment, it will experience less resistance compared to the core fluid. This means that the sheath 
fluid fills the top and bottom of the channel and wraps around the core fluid, and exerts vertical 
force as well as lateral force, such that the core fluid is placed at the center of the channel.   
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Figure 5.1 (a) Schematic of the microfluidic particle/fiber fabrication using photopolymerization 
strategy. (b) The photopolymerization process of PEGDA hydrogels.  
 
5.3.1 Microfluidic PEGDA particle fabrication 
The experimental set-up for the fabrication of spherical particles is shown in Figure 5.2 
(a). The microchannel is vertically positioned and the UV light with the intensity of 340 mW is 
irradiating at the outlet of the channel. The SEM images of one of the particles, which is depicted 
in Figure 5.2 (b), shows the symmetric shape of the spherical particles. The effect of flow rate 
ratio on the diameter (±standard error) of the particles is demonstrated in Figure 5.2 (c). This 
figure shows that a wide range of diameter could be created simply by changing the flow rate ratio 
between the two fluids. When the shear-to-core flow rate ratio decreases from 50:2 to 100:8, the 
diameter of the particles increases by a factor of 4.6. Additionally, the low standard errors 
demonstrates the uniformity of the particles.  
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Figure 5.2 Microfluidic spherical PEGDA particle fabrication. (a) Experimental set-up: the 
microchannel is vertically positioned and the UV light is irradiating at the outlet of the channel.   
(b) SEM image of a particle made by the sheath-to-core flow rate of 100:40. (c) The diameter of 
the particles made by different flow rate ratios.  
 
5.3.2 Microfluidic PEGDA fiber fabrication 
Miscible fluids were applied in order to create a continuous core flow, which can be 
polymerized as the microfibers. Figure 5.3 (a) shows the experimental set-up and the continuity 
of the PEGDA microfiber fabrication. One of the advantages of using ultraviolet light is the rapid 
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polymerization that help design and fix fibers with various noncircular cross-sections. On the other 
hand, in other solidification methods such as phase inversion or chemical cross-linking, the cross-
section of the fibers are affected by the surface tension in the two-phase systems due to their slow 
solidification rates. The SEM image of the PEGDA fibers with longitudinal view is shown in 
Figure 5.3 (b). This figure demonstrates that there is no shape gradient across the length of the 
fiber. The SEM images of the cross-section of the fibers fabricated with different flow rate ratios 
are depicted in Figure 5.3 (c1,2-f1,2). In these figures, the effect of hydrodynamic focusing force 
from the sheath fluid to the core fluid in both lateral and vertical directions can be clearly observed. 
The roughness of the fibers made by different flow rates are negligible due to the rapid 
polymerization process, which minimizes the diffusion at the fluid/fluid interface.  
The results of quantitative analysis on the size of the PEGDA fibers are demonstrated in Figure 
5.3 (g). This figure shows that the width of the fiber increases as the sheath-to-core flow rate ratio 
decreases from 100:40 to 100:100. That was expected, because when the flow rate ratio reduces, 
the velocity gradient at the interface decreases, which results in the weakening of the lateral shear 
force exerted on the core fluid from the sheath fluid. Consequently, the core fluid expands laterally 
in the channel, which results in the fabrication of fibers with higher width. When the flow rate 
ratio decreases from 2.5 to 1, for instance, the width of the PEGDA fiber increases by 42%. 
However, the height of the fibers does not change significantly due to the fact that the height of 
the fiber is dependent on the vertical force on the core fluid from the sheath fluid. The vertical 
hydrodynamic force is mostly dependent on the number of the chevrons, which were kept constant 
in this study [42]. Additionally, the microfluidic fiber fabrication process was simulated using 
COMSOL Multiphysics. Both of the Stoke’s and Fick’s equations were solved in order to obtain 
concentration distributions of the core and sheath fluid along the channel. Figure 5.3 (c3-f3) shows 
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the concentration distribution of the core and sheath fluids at the outlet of the channel. The red and 
blue colors represent the core and sheath fluids, respectively. The results demonstrated the same 
behavior as the experimental result, which reflects consistency between the numerical and 
experimental results.  
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Figure 5.3 Microfluidic PEGDA fiber fabrication. (a) The experimental set-up, which is similar 
to the set-up used for particle fabrication. (b) The longitudinal SEM image of the PEGDA fibers 
made by the sheath-to-core flow rate of 100:100 μL/min. (c1, 2-f1, 2) The cross-section SEM images 
of the fibers made by different flow rates of 100:40 μL/min to 100:100 μL/min, respectively. (c3-f3) 
The numerical results made by simulating the microfluidic fiber fabrication. (g) Dimensions of the 
PEGDA fibers made by different sheath-to-core flow rate ratios. 
 
Because fibers have a higher surface to volume ratio than the spherical particles, they can 
play more effective roles in biomedical applications like  tissue engineering. In addition, lower 
UV intensity is needed to polymerize the microfibers compared to the spherical particles, which is 
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an advantage when biological molecules, such as cells or bacteria, are incorporated into the 
process.  
 
5.3.3 Mechanical properties of the PEGDA microfibers 
The mechanical properties of the PEGDA microfibers with different characteristics were 
studied in this work. The effect of flow rate ratio between the core and sheath fluids on the 
mechanical properties were investigated. Additionally, we incorporated collagen and glucose into 
the PEGDA fibers to study their influence on the tensile properties of the resulting fibers. Collagen 
is a natural polymer that could improve the biocomatibility of the resulting fibers. Figure 5.4 (a 
and b) shows the tensile properties of the PEGDA fibers with different characteristics.  
 
  
Figure 5.4 Tensile properties of the PEGDA fibers with different characteristics. (a) Pure PEGDA 
fibers fabricated with different flow rate ratios between the core and sheath fluids. (b) The effect 
of incorporation of collagen and glucose on the mechanical properties of the fibers. The flow rate 
ratio was kept constant at 100:60 μL/min. The concentrations of PEGDA and PI were 30 % and 
2%, respectively, for all of the fibers.  
 
0 10 20 30 40 50
0
1
2
3
4
5
6
Te
ns
ile
 S
tre
ss
 (M
P
a)
Strain (%)
 Flow Rate Ratio 100:40
 Flow Rate Ratio 100:60
 Flow Rate Ratio 100:80
0 10 20 30 40 50 60 70
0
1
2
3
4
5
6
7
Te
ns
ile
 S
tre
ss
 (M
P
a)
Strain (%)
 Pure PEGDA
 1% Collagen/PEGDA
 1% Glucose/PEGDA
(a) (b) 
107 
 
Stress at break (MPa), Strain at break (%), and Young’s modulus (MPa) of different types 
of PEGDA fibers were averaged and listed in Table 5.1 as well. The stress-strain curves of the 
PEGDA fibers demonstrate that all of the fibers made in this study are brittle, which might be due 
to the chemical cross-linking of PEGDA during the fiber fabrication process. When the core flow 
rate increases from 40 μL/min to 80 μL/min, the strain at break (%) decreases by a factor of 1.3, 
whereas the stress at break (MPA) and Young’s modulus (MPa) become  1.3 and 1.6 times. That 
was expected because when the core flow rate increases, the cross-linking density increases, which 
results in the formation of more brittle structures. 
 
Table 5.1 Mechanical properties of the PEGDA fibers. 
Sample Flow Rate Ratio 
(Sheath:Core)
Stress at 
Break (MPa)
Strain at Break 
(%) 
Young’s 
Modulus (MPa)
30% PEGDA 100:40 5.6 ± 1.1 43.6 ± 5.0 10.3 ± 1.1 
30% PEGDA 100:60 5.9 ± 0.6 39.7 ± 2.7 14.1 ± 1.4 
30% PEGDA 100:80 7.4 ± 2.1 34.2 ± 7.1 16.8 ± 1.2 
1% Collagen/30% PEGDA 100:60 3.7 ± 1.0 42.5 ±7.2 6.7 ± 0.4 
1% Glucose/30% PEGDA 100:60 6.5 ± 1.0 33.9 ± 3.9 19.0 ± 1.3 
 
Apart from changing the flow rate ratio, collagen and glucose were incorporated into the 
PEGDA fibers to investigate their effects on the mechanical properties of the PEGDA fibers. It 
was found that when 1 v% collagen is added to the core solution, the stress at break (MPa) and 
Young’s modulus (MPa) drops by 38% and 53%, respectively, whereas the strain at break (%) 
increases by a factor of 1.07. The reason for increasing the strain at break (%) can be due the fact 
that the collagen molecules do not react with UV light and the photoinitiator. As a result, they 
hinder part of the cross-linking binding, which makes the network less brittle. Additionally, it was 
expected to obtain lower stress at break and Young’s modulus because the mechanical properties 
of the natural polymers are lower than those of the synthetic polymers. Therefore, by blending 
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PEGDA, which is a synthetic polymer, with collagen, the resulting mixture will have lower 
mechanical properties. In addition, the results show that the both elastic modulus and stress at 
break of the fibers increase by a factor of 1.1 and 1.34, respectively, when the PEGDA fibers 
include 1% glucose. That might be due to the high mechanical properties of the PEGDA fibers.  
 
5.3.4 Surface study of the PEGDA fibers  
The PEGDA microfluidic-spun fibers fabricated in this study have the potential to be used 
in biomedical applications such as cell delivery, drug delivery, and tissue engineering. We 
incorporated different materials, such as glucose, sucrose, gelatin, collagen, PEG, and PVA, into 
the PEGDA fibers and soaked the resulting fibers in water for 6 days at 37 °C.  
It was found that adding the glucose, gelatin, and PEG do not create a significant porosity on the 
surface of the fiber (data not shown). However, PEGDA fibers with porous surfaces were created 
by incorporating sucrose and PVA into the fiber. Figure 5.5 shows the SEM images from the 
longitudinal view of the fibers made by PEGDA/sucrose, PEGDA/PVA, and PEGDA/collagen. 
The results show that incorporating PVA into the PEGDA fibers (Figure 5.5 (a1, a2)) results in 
formation of porosity at the groove areas of the fibers, whereas sucrose can create porosity in all 
parts of the fibers (Figure 5.5 (b1, b2)). Although collagen does create porosity on the surface of 
the fiber, it increases the roughness, which could be desirable for a specific applications (Figure 
5.5 (c1, c2)). Additionally, incorporation of a natural polymer into a synthetic polymer increases 
the biocompatibility of the network due to the fact that biological characteristics such as cell 
adhesion will be enhanced. 
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Figure 5.5 SEM images of the (a) 30%PEGDA/2% PVA, (b) 30% PEGDA/10% sucrose, and (c) 
30% PEGDA/1% collagen after soaking them in water for 6 days at 37 °C. 
 
 
5.3.5 Cell encapsulating in PEGDA fibers  
We encapsulated adult hippocampal progenitor cells (AHPCs) into the PEGDA fibers by 
mixing a cell suspension solution with hydrogel pre-polymer solution containing a photoinitiatior 
to polymerize the PEGDA. We performed the cell viability assay by means of Propidium Iodide 
(PI) after 6 hours and no cells survived this experiment. We thought about different possibilities 
that may resulted in dying the cells inside of the PEGDA network. In order to increase the cell 
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survival, we did not use photoinitiator, UV light, and the microfluidic fiber fabrication channel. 
Rat bone marrow derived mesenchymal stem cells (uMSCs) were also used for the cell viability 
because they are more resilient to environmental changes compared to AHPCs. Additionally, a 
very low concentration of PEGDA (5% and 10%) was used as the pre-polymer solution. These 
solutions were mixed with the cell suspension and incubated at room temperature for 20 minutes 
on a rotator. After 20 minutes, cells were centrifuged at 800 rpm for 5 min in order to remove the 
PEGDA solution from the cells. Cells were then plated onto coated poly-L-ornithine (10 μg mL–1; 
Sigma-Aldrich) and purified mouse laminin glass coverslips. The cell viability results for both of 
the AHPCs and uMSCs were shown in Figure 5.6 and Figure 5.7, respectively. The figures 
demonstrate that the AHPCs control samples containing no PEGDA solutions, had processes and 
were phase bright, whereas those in the PEGDA solutions were dark, no processes and had 
vacuoles forming around cells indicating possible cell death. uMSC controls were all adherent 
after 24 hours and had very little floating cells. uMSCs exposed to PEGDA solutions were more 
rounded cells and did not flatten out. These cells also had vacuoles forming indicating cell death. 
Additionally, both AHPCs and uMSCs did not survive the experiment as indicated through the 
positive propidium iodide labeling. Based on the cell viability results, we concluded that the 
PEGDA (Mn=575) is not ideal for cell encapsulation. For the future work, we can consider other 
hydrogels, which provide a biocompatible environment for the cells. Additionally, using PEGDA 
with higher molecular weight could be another solution, but PEGDA with high molecular weights 
are very expensive, which is not consistent with the cost effective aspect of microfluidic approach. 
Nevertheless, the bow tie shaped PEGDA fibers could be useful for aligning the neural cells. 
Compared to round fibers, the bow tie shaped fibers can catch more cells in their groove regios, 
which makes the tissue regeneration process more efficient.   
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Figure 5.6 Propidium Iodide assay for AHPCs after 1 DIV. (A,D,G,J) shows Cy3 labeling in red. 
(B, E, H, K) shows DAPI staining in blue. (C, F, I, L) shows merged image of Cy3 and DAPI. (J) 
serves as a positive reagent control. Cells were exposed to 70% ethanol to purposefully kill cells 
in order to test if propidium iodide reagent was working properly. All dead cells would take up the 
propidium iodide and fluoresce red. 
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Figure 5.7 Propidium Iodide assay for uMSCs after 1 DIV. (A,D,G,J) shows Cy3 labeling in red. 
(B, E, H, K) shows DAPI staining in blue. (C, F, I, L) shows merged image of Cy3 and DAPI. (J) 
serves a positive reagent control. Cells were exposed to 70% ethanol to purposefully kill cells in 
order to test if propidium iodide reagent is working properly. All dead cells would take up the 
propidium iodide and fluoresce red. 
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5.4 Conclusions 
We used microfluidic approach and photopolymerization strategy to fabricate PEGDA 
spherical particles as well as bow tie shaped fibers. The effect of the flow rate ratio between the 
core and sheath fluid on the size of the particles and fibers were investigated. It was found that the 
decrease of the flow rate ratio between the fluids increases the diameter and width of the particles 
and fibers, respectively. The tensile properties of the PEGDA fibers were studied as well. It was 
found that when the core flow rate increases, the cross-linking density increases, which results in 
the fabrication of more stiff and brittle fibers. Collagen and glucose were incorporated into the 
PEGDA fibers and their effects on the tensile properties were studied. The results showed that the 
mechanical properties of the PEGDA/collagen mixture drops due to the low strength of the 
collagen, which is a natural polymer. On the other hand, it was found that the presence of glucose 
in the PEGDA/glucose network can improve the mechanical properties. We studied the effect of 
adding different materials such as glucose, sucrose, gelatin, collagen, PVA, and PEG into the 
PEGDA network. Based on the SEM images, it was observed that the porosity of the fiber can be 
tuned by incorporating sucrose and PVA into the PEGDA fibers. In addition, we encapsulated 
AHPCs into the PEGDA fibers in order to create a cell-laden fiber. Propidium Iodide (PI) was 
used to examine cell viability, and the results showed that the cells could not survive. We provided 
a more biocompatible condition by mixing the cell suspension solution with low concentrated 
PEGDA (Mn=575) solution for 20 minutes in the absence of photoinitiator, UV light, and 
microfluidic fiber fabrication process, but the cells still did not survive. We believe that another 
polymer or the same polymer with higher molecular weight needs to be used in order to increase 
the cell survival into the hydrogel network.  
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CHAPTER 6 
FUTURE WORK 
It was found that the microfluidic fiber fabrication approach is a functional device that 
could be utilized in biomedical applications such as tissue engineering, cell delivery, and drug 
delivery.  
As mentioned in chapter 4, we plan to have three replicates of cell seeding on the PCL 
fibers, each made with different characteristics, to investigate quantitatively which one can provide 
the best conditions in terms of cell adhesion, proliferation, and differentiation. One of the replicates 
was finished and the results were provided in chapter 4. Two more replicates are needed in order 
to obtain more reliable results about cell behavior on different types of fibers.  
The PCL fibers can be embedded inside of the conduits in order to create a 3D environment 
for the cell culture that could be more effective in terms of nerve tissue regeneration, which makes 
it one step closer to the application of the PCL fibers in tissue engineering.  
As mentioned in chapter 5, we tried to encapsulate different types of cells into the PEGDA 
hydrogel networks to create a cell-laden fiber. However, the cells did not survive even after 
removing photoinitiator and UV light. In order to resolve this problem, we can use another polymer 
with high biocompatibility or we can change our solidification strategy to chemical cross-linking. 
Nevertheless, the bow tie-shaped fibers have a groove on their surfaces, which could be useful for 
aligning cells. We believe that the grooves embedded on the surface of the PEGDA fibers can 
make the tissue regeneration process more effective since they are able to provide a 3D 
environment for the cells. In addition, the cell adhesion on this type of fibers will be significantly 
higher compared to the round shaped fibers.  
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As mentioned in chapter 1, the microfluidic spun microfibers could have applications in 
drug delivery devices. In this area, we can use blend of polymers or different concentrations of 
cross-linking agents to design flexible microfiber-based for in-vivo drug release according to the 
requirements of different medications. 
Luminescent nanospecies could be incorporated into the microfibers using a microfluidic 
platform, which may have application for bio-imaging or bio-markers for wound dressing, tissue 
engineering, and drug delivery.  
The mechanical properties of the cells could be measured by the microfluidic spun fibers 
by measuring the mechanical properties of the fibers both with and without the cells, and 
calculating the difference. However, it is predicted that there might be some challenges in terms 
of the accuracy and resolution of the equipment used that need to be considered during this study.  
